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Abstract
Currently, the captive African elephant population in North America is not self-sustaining. An
increase in acyclicity has been documented among post-pubertal females of all ages. Due to
ethical issues and cost, importation of new animals is not feasible at this time; therefore, it is
imperative that all post-pubertal females within zoological facilities be reproductively viable.
The main objectives of these projects were to assess the reproductive status of the captive
population and to identify contributing factors to acyclicity. In addition, prevention and
treatment protocols were to be designed to promote reproductive proficiency in all reproductiveage females to avert the population collapse that has been predicted.
Experiment 1
A written survey assessed reproductive status of female Asian and African elephants in
AZA/SSP facilities in 2008, and data were compared to surveys conducted in 2002 and 2005.
Results showed ovarian acyclicity rates across the surveys remained unchanged for Asian (13.3,
10.9 and 11.1%) and African (22.1, 31.2 and 30.5%) elephants, respectively (P>0.05), but were
higher overall for African compared to Asian elephants (P<0.05). In 2008, the percentages of
Asian and African elephants with irregular cycles (14.3 and 15.8%) and irregular + no cycles
(25.4 and 46.4%) was similar to 2005 (7.6 and 11.8%; 18.5 and 43.0%), but were increased
compared to 2002 (2.6 and 5.2%; 16.0 and 27.3%), respectively (P<0.05). For both species,
ovarian acyclicity increased with age (P<0.05). Reproductive tract pathologies did not account
for the majority of acyclicity, although rates were higher in noncycling females (P<0.05). Bull
presence was associated with increased cyclicity rates (P<0.05) for Asian (92.5 versus 58.3%)
and African (64.9 versus 57.8%) elephants compared to females at facilities with no male,
respectively. Cyclicity rates were higher for Asian (86.8 versus 65.2%) and African (67.9 versus
56.7%) elephants managed in free compared to protected contact programs (P<0.05),
respectively. Geographical facility location had no effect on cyclicity (P>0.05). In summary,
incidence of ovarian cycle problems continues to predominantly affect African elephants.
Although percentages of acyclicity did not increase between 2005 and 2008, 42.2% Asian and
30.2% African females were no longer being hormonally monitored; thus, reproductive cycle
abnormalities could be worse than current data suggest.
Experiment 2
This paper described anti-Müllerian hormone (AMH) secretion in Asian and African elephants of
different age groups and reproductive status. Overall mean concentrations did not differ
(P>0.05) between species, but were markedly higher in male than female Asian (31.01 ± 4.22
ng/mL, 0.19 ± 0.02 ng/mL) and African (40.27 ± 3.18 ng/mL, 0.17 ± 0.04 ng/mL) elephants,
respectively. Anti-Müllerian hormone secretion was not related to ovarian cyclicity status
(cycling vs. noncycling) (P>0.05), but was higher in prepubertal (0.40 ± 0.10 ng/mL) compared

ii

to reproductive age (8-35 years old; 0.18 ± 0.04 ng/mL) and aged (≥36 years old; 0.16 ± 0.03
ng/mL) females (P<0.05). In males, AMH secretion was not affected by musth status, but was
age-related (P<0.05), with concentrations being higher in prepubertal (49.08 ± 6.11 ng/mL) as
compared to aged (≥36 years old) (22.27 ± 5.82 ng/mL) bulls; concentrations in mature bulls (835 years of age) (37.01 ± 3.17 ng/mL) were similar to prepubertal and older bulls (P>0.05). We
concluded that circulating AMH concentrations in elephants were similar between species and
not affected by reproductive status; however, concentrations were significantly higher in males
than females, and were elevated in younger animals. The diagnostic value of AMH to assess
fertility status of individual elephants remains to be determined.
Experiment 3
Currently, reproductive age (11-35 years old) female African elephants (Loxodonta africana) in
U.S. zoos are experiencing high rates of ovarian cycle problems (>40%) and low reproductive
success. Previously, one-third of acyclic females exhibited hyperprolactinemia, a likely cause of
ovarian dysfunction. This follow-up study examined the current state of hyperprolactinemia in
African elephants and found the incidence has increased significantly to 71%. Circulating serum
progestagens and prolactin were analyzed in 31 normal cycling, 13 irregular cycling, and 31
acyclic elephants for a 12-month period. In acyclic females, overall mean prolactin
concentration differed from cycling females (P<0.05), with concentration being either
higher (n=22; 54.90 ± 13.31 ng/mL) or lower (n=9; 6.47 ± 1.73 ng/mL) than normal. No
temporal patterns of prolactin secretion were evident in elephants that lacked progestagen cycles.
In cycling females, higher concentrations of prolactin were observed during nonluteal (34.38 ±
1.77 and 32.75 ± 2.61 ng/mL) than luteal (10.51 ± 0.30 and 9.67 ± 0.42 ng/mL) phases for
normal and irregular females, respectively. Overall prolactin means did not differ (P>0.05)
between normal (16.11 ± 2.89 ng/mL) and irregular (15.03 ± 4.17 ng/mL) cycling females. Of
most concern was that over two-thirds of acyclic females now are hyperprolactinemic, a dramatic
increase from the one-third observed 7 years earlier. Furthermore, females of reproductive age
constituted 45% of elephants with hyperprolactinemia. Until the cause of this problem is
identified and/or a treatment is developed, reproductive rates will remain suboptimal and the
population non-sustaining.
Experiment 4
Perturbations in serum prolactin concentration have been identified as a common symptom
among captive acyclic African elephants. In the human, hyperprolactinemia and prolactin
deficiencies are significant causes of amenorrhea. Pituitary prolactin is held under constant
inhibition by a hypothalamic derived neurotransmitter, dopamine; thus, regulation via exogenous
treatment with antagonists or agonists has been successful in reinitiating normal ovarian cycles.
Oral administrations of Cabergoline (dopamine agonist; n=4) and domperidone (dopamine
antagonist; n=4) were studied as possible treatments for hyperprolactinemia or prolactin
deficiency, respectively. Changes in serum prolactin and progestagen concentrations in response
to treatment were evaluated to determine if regulation of prolactin synthesis can reinitiate normal
estrous cyclicity. Overall mean prolactin concentration decreased (P = 0.01) in cabergoline
treated females (32.22 ± 14.75 ng/mL) when compared to controls (77.53 ± 0.96 ng/mL).
Overall mean progestagen concentrations increased (P < 0.05) in treated females (0.15 ± 0.01
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ng/mL). In contrast, control hyperprolactinemic females maintained mean baseline progestagen
concentration (0.07 ± 0.01 ng/mL). Overall mean prolactin concentration increased (P = 0.005)
during times of domperidone treatment (21.77 ± 3.69 ng/mL) when compared to controls (5.77 ±
0.46 ng/mL). Overall mean serum progestagen concentration was not significantly different in
the treated group (0.11 ± 0.01 ng/mL) when compared to controls (0.07 ± 0.01 ng/mL). In
conclusion, prolactin synthesis can be regulated with either a dopamine agonist or antagonist
resulting in a decrease or increase in serum prolactin concentration, respectively. Although
serum progestagen concentration increased in response to Cabergoline treatment, whether
estrous cyclicity sufficient for successful breeding was reinitiated could not be determined.
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Literature Review

Natural History

Social Structure

Wild female African elephants live in a fission-fusion matriarchal society involving four tiers
of social interactions: cow-calf units, family groups, kinship/bond groups, and clans. Cow-calf pairs
are the most basic unit that make up the family group consisting of mothers, daughters, sisters, aunts,
and immature males (Douglas-Hamilton, 1975; Moss and Poole, 1983; Wittemyer et al., 2007).
Typically, the largest female assumes the role of the matriarch of a herd, which is composed of a
family group of cow-calf units; all individuals within a family group are genetically related. The
matriarch’s job entails coordinating protection of the herd, finding valuable resources, and
contributing genetically (Douglas-Hamilton, 1975; Dublin, 1983; Poole and Moss, 1989; McComb et
al., 2001). Herd sizes vary according to available resources, with an average size in most African
countries ranging from five to fifteen adult females (cows) and their offspring (calves). Herds
consisting of over 100 individuals have been documented; however, if a family group gets too big for
the available resources; mature females will leave and form smaller family groups. The newly formed
family groups will stay in close contact with their maternal herd for their entire life forming what is
termed a kinship/bond group. Bond groups consist of multiple family groups that share a home
range. Kinship/bond groups are important as they function to aid in group defenses and
allomothering, which allows for young, nulliparous females to learn how to care for young and
enables nursing mothers sufficient time to forage (Douglas-Hamilton, 1975; Moss and Poole, 1983;
Lee, 1987). Furthermore, elephants are known to congregate into clans. Elephant clans consist of
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family and bond groups of unrelated elephants that share territory intermittently, i.e., watering holes
and food browsing areas. An elephant family group’s home range can stretch for 10-20 kilometers
during the wet season with documented daily migrations during drought reaching 200 kilometers
(Rodgers and Elders, 1977; Douglas-Hamilton, 1998).

The life of the adult male (bull) is in stark contrast to its female counterpart. As young bulls
reach sexual maturity, they begin to spend more time at the edge of the herd, gradually leaving for
hours or days at a time. Eventually, days become weeks and around the age of 14 years the sub-adult
male leaves his family group (Douglas-Hamilton, 1975). While males live primarily solitary lives,
they frequently form loose associations with other males called bachelor herds. Males in bachelor
herds forage together, work cooperatively in group defense behaviors, and spar with one another
(Poole, 1987). Males usually stay in bachelor herds until they have matured to an age where they
experience musth, a state of heightened sexual arousal. Regardless, bull society, much like within
family groups, has a dominance hierarchy within a given territory with the musth bull becoming the
dominant figure (Hall-Martin, 1987; Poole, 1989). Musth is an annual episode of sexual excitement
for male elephants that is comparable to rut in male ungulates (Poole, 1987). During periods of
musth, which usually lasts 1-3 months depending on individual fitness, bulls only interact with
breeding cows or other musth bulls. Only the most dominant males will be allowed to interact with a
herd, and be permitted to breed with females in standing heat or estrus. Fights over breeding
opportunities between musth bulls can last from minutes to hours and, although rare, can end in
death. Usually the older bulls, forty to fifty years of age, do most of the breeding (Poole and Moss,
1981; Poole, 1987).

2

Communication

Elephants communicate in a multitude of ways. When in close proximity to one another
elephants can communicate tactilely and visually through touch and body posturing (Kahl and
Santiapillai, 2004). Because of their social structure, elephants need to communicate over great
distances to warn family, kinship/bond group, or clan members about impending danger or to signal
musth males during times of breeding opportunities. Elephants are able to transmit messages over a
distance of approximately 10 kilometers vocally via infrasound and chemically through pheromones
secreted in urine and temporal gland secretion (Poole et al., 1984; Payne et al., 1986; Langbauer et
al., 1989; Rasmussen and Schulte, 1998).

Communication via subsonic vocalizations and chemical signals becomes very important
during breeding times when females have to convey their physiological status to potential suitors
(Poole and Moss, 1989). Mature male elephants in their twenties will annually experience a period of
musth (Poole and Moss, 1981). During this time the male will focus all of his energy on fighting
other musth bulls for breeding opportunities with estrus females, breeding, and mate guarding. A
male has to be of a specific age and body condition to go into musth; thus, the fit, strong mature bulls
are preferred to father offspring (Poole, 1989). Notably, a bull does not have to be in musth to be
fertile; however, musth gives the bull the advantage when fighting off other dominant bulls and
attracting females (Hildebrandt et al., 2000b). The musth bulls communicate to other males and
females by constantly dribbling urine, which contains pheromones, in addition to the steroids and
pheromones being secreted from temporal glands (Poole and Moss, 1981; Poole, 1987). Specifically,
the composition of the temporal gland secretion shifts from predominantly dihydrotestosterone
(DHT) to testosterone (Jainudeen et al., 1972; Rasmussen et al., 1984; Hall-Martin, 1987; Rasmussen
et al., 1996). As shown in studies with captive elephants, cows with no previous exposure to bulls
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exhibit an increased state of excitation while investigating temporal gland secretion from a musth bull
when compared to a non-musth male (Schulte and Rasmussen, 1999). Furthermore, the
concentration of circulating testosterone found in blood serum and temporal gland secretion can
increase from 0.04-0.46 ng/ml and 0.05-0.50 ng/ml in non-musth bulls to 150 ng/ml and ≥ 300 ng/ml
during musth, respectively (Poole and Moss, 1981; Hall-Martin, 1987; Poole, 1987; Poole, 1989;
Rasmussen et al., 1996; Ganswindt et al., 2005a and 2005b). Exposure to musth bulls could be
necessary to stimulate normal ovarian cyclicity; however, that has yet to be determined.

Diet

An adult elephant can consume between 68 to 91 kg or 1.5-1.9% of its body mass daily.
Individual variations of daily dry matter intake are dependent on dry matter digestibility and animal
characteristics: age, reproductive status, gender, and activity level (Clauss et al., 2003a). Wild
elephants are described as browsers and have been documented to consume more than 400 different
plant species daily during the wet season. However, even though they appear to be generalized
eaters, elephants actually have a very specific diet (Dougall and Sheldrike, 1964; McCullagh, 1969;
Buss, 1990), wherein grasses are the most prevalent food item (Field, 1976; Chaika, 1996). Having a
monogastric digestive system, with an enlarged pouch at the beginning of the large intestine called a
cecum that allows for microbial fermentation of fibrous diets, elephants have to eat almost constantly
to fuel their large bodies (Dierenfeld, 1994). Elephants, in general, display low diet digestibility
compared to other herbivores with similar diets. Dry matter digestibility in captive African elephants
ranged from 22% to 39% when fed mixed grasses hay to exceeding 62% when fed alfalfa hay
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(Roehrs et al., 1989). Field studies that utilized lignin ratio technique as an internal marker suggested
average dry matter digestibility of 30% to 45% for free-ranging wild elephants (Dierenfeld, 1994).

Overall, the diet of the elephant contains 8-10% crude protein with slight fluctuations in
protein content in plants during dry versus wet seasons (Lindsay, 1994). Certainly, when foodstuffs
are plentiful the elephant consumes more dry matter and subsequently more protein; however, the
elephant will adjust its diet accordingly. Sub-Saharan trees contain high concentrations of protein
binding soluble condensed tannins. During the wet season, elephants not only ingest more protein
rich plants, but also add more bark and leaves from tannin rich trees to increase crude fiber content in
the diet, which subsequently balances the diet ensuring daily protein content remains at 10-12%
throughout the year (McCullagh, 1969). In addition, 1.2-1.8% lipid, 43-62% fiber, as well as
vitamins and minerals via consumption of twigs, bark, and even soil are considered the dietary norm
(McCullagh, 1973; Sukamar, 2003). In contrast, captive elephants are fed daily diets of
approximately 8-10% crude fiber and ≥ 30% crude protein consisting of highly digestible grain
pellets and mixed-grasses hay (Hatt and Clauss, 2006; Masuri, 2007).

Reproduction

Puberty

Puberty in wild female elephants occurs between 8 to15 years of age. Puberty for the female
is defined as the time of first estrus (Perry, 1953; Sukumar, 1994). If successful, the estrus will be
accompanied by a fertile mating with a male and after a 22 month gestation, a healthy calf (Hodges,
1998). Considering that elephants have a long lifespan and survive up to 70 years in the wild, some
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females reproduce well into their 50s; thus, they can have a reproductive lifespan of ≥ 40 years (Laws
1969; Whitehouse and Hall-Martin, 2000; Moss, 2001). In general, wild elephants are either
pregnant or in lactational anestrous (Hall-Martin, 1987) with an average calving interval of 4-6 years
(Moss and Poole, 1983). Data collected from culled elephants in Kruger National Park, South Africa
between 1975 and 1995 showed that reproductive success declines sharply as females age,
specifically around the age of 50 (Freeman et al., 2009b). Ovarian morphological data collected from
culled wild females in African game parks also suggested that females ≥ 50 years of age have nearly
exhausted follicular reserves (Perry, 1953; Laws, 1969). Moreover, at this time in an elephant’s life
she is taking on more of an alloparenting role, spending more time helping rear calves within the
family (Douglas-Hamilton, 1975; Lee, 1987; Wittemyer et al., 2007). Similar data from culling have
shown rare cases of wild cows that have never had calves and appear to experience reproductive tract
pathologies including endometrial, uterine, and/or ovarian cysts (Freeman et al., 2009b).

In contrast, captive elephants reach puberty at a significantly earlier age with the majority of
females having obtained maturity (first estrus) at 7 years of age (Brown, 2000). In one case, an Asian
female elephant was impregnated at the age of two and gave birth at age four (Keele et al., 2007).
Currently, only 38.9% of all captive reproductive age African females in North America have a
breeding history either via live cover by a bull or artificial insemination, with less than half of those
individuals successfully conceiving and able to carry calves full term (Olson, 2008). Furthermore,
the majority of captive cows that have never experienced pregnancy seem to exhibit higher
incidences of reproductive tract pathologies and abnormal estrous cyclicity that appears to have
progressively worsened over the last six years (Brown, 2000; Brown et al., 2004a; Hermes et al.,
2004; Proctor et al., 2009).

6

Estrous Cycle: Captive Population

The captive female elephant exhibits a long spontaneous estrous cycle that is 14-16 weeks in
length consisting of a 4-6 week follicular phase and 8-10 week luteal phase; approximately 3-4
estrous cycles per year (Plotka et al., 1988; Hodges, 1998; Brown, 2000). The elephant’s estrous
cycle is at least three times longer in duration when compared to other species: the horse, sheep,
cattle, and guinea pig (all 16-21 days), rat (4-5 days), and menstrual cycle of the primate (28 days)
(Draincourt et al., 1993). The elephant is a monovular, non-seasonal breeder, regardless of habitat or
environment, i.e., wild or captive (Short, 1966; Hildebrandt et al., 1996; 2000a; Hermes et al., 2000;
Schulte et al., 2000). However, in wild populations, more breeding and calving has been documented
during the rainy season when resources are most abundant (Douglas-Hamilton, 1975; Moss and
Poole, 1989). Unlike the homosexual behaviors observed in cattle such as females mounting estrus
females, the female elephant does not show any outward signs of estrus or heat (Katz and McDonald,
1992). Thus, hormone profiles assayed from urine, feces, and/or blood collection are necessary to
monitor ovarian cyclicity. In wild populations the bull elephant is able to detect estrus via
pheromones excreted in urine and temporal gland secretion using only the vomeronasal organ located
in the roof of his mouth (Rasmussen, 1998; Rasmussen and Schulte, 1998; Bagley et al., 2006).

Follicular Phase

At the onset of the 4-6 week follicular phase, follicle stimulating hormone (FSH) is the
dominant reproductive hormone in circulation (Brown et al., 1999a; 2004b). Follicle stimulating
hormone is a glycoprotein that is synthesized and secreted by gonadotrophic cells in the anterior
pituitary in response to pulsatile secretion of hypothalamic gonadotropin-releasing hormone (GnRH)
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(Phifer et al., 1973) and granulosa cell derived activin (Bilezikjian et al., 2004). Follicle stimulating
hormone targets a specific G-protein coupled transmembrane receptor found on granulosa cell
membranes in developing preantral follicles (Richards, 1980; Funkenstein et al., 1984). Important for
selection, growth, and development of follicles, FSH also acts at the granulosa cell to convert
testosterone from theca interna cells into estradiol (E2) by increasing the activity of the aromatase
enzyme (Fitzpatrick and Richards, 1991). Although not yet proven in the elephant, it is thought that
like in other species, estradiol enters the vascular circulation transported by sex-hormone binding
globulin to target estradiol-α receptors (ERα) in the arcuate nucleus of the hypothalamus allowing for
the negative feedback regulation of tonic GnRH secretion and subsequent luteinizing hormone (LH)
synthesis and secretion by gonadotrophic cells in the anterior pituitary (Goodman et al., 1980). Since
GnRH neurons do not express ERα, it is hypothesized estradiol works indirectly through other
neurotransmitters to inhibit GnRH neurons (Lehman and Karsch, 1993; Lehman et al., 1993). A
possible candidate for local control of GnRH release is kisspeptin (kiss-1); kiss-1 neurons express
ERα (Franceschini et al., 2006). In the sheep (Pompolo et al., 2006), primate (Silverman et al.,
1977), and rodent (Clarkson and Herbison, 2006) GnRH neurons are found in close apposition to
projections from kiss-1 neurons. Moreover, GnRH neurons express the kiss-1 receptor, GPR-54
(Clarkson et al., 2008). Kisspeptin has been shown to increase GnRH secretion during the estrous
cycle thereby increasing FSH and LH secretion (Pompolo et al., 2006); binding of estradiol to kiss-1
neurons inhibits synthesis and secretion of kiss-1 and subsequent GnRH secretion and pituitary
gonadotropins (Pielecka-Fortuna et al., 2008). In addition, kiss-1 may also act directly or indirectly
on intermediary γ-aminobutyric acid (GABA) releasing neurons to regulate GnRH secretion
(Pielecka-Fortuna et al., 2008; Zhang et al., 2009).
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As the follicular phase progresses, FSH from the anterior pituitary decreases from its peak
concentration of approximately 25 ng/ml to a baseline of 6 ng/ml just before the ovulatory LH surge
(Brown et al., 1991; Brown et al., 1999a; Brown et al., 2004b). As seen in other species, secretion of
inhibin, produced by granulosa cells of the growing follicles, follows an inverse pattern to that of
FSH, and along with estradiol begins to suppress FSH (Brown et al., 1991). Inhibin, a heterodimeric
glycoprotein and member of the transforming growth factor-β family (TGF-β), acts at the pituitary
level through serine-threonine receptors on gonadotrophic cells to selectively suppress synthesis of
the FSH β unit (Vale et al., 1990). In addition, inhibins have been shown to exert an antagonistic
effect by competing with activins. Activins are members of the TGF-β family that are both
stimulatory to and stimulated by FSH (Bilezikjian et al., 2006).

In addition to the secretion of estradiol and activin, the developing follicles also produce antimüllerian hormone (AMH). Like activin, AMH is a member of the TGF-β family; AMH is produced
in primary, secondary, and small antral follicles in the post-pubertal ovary by granulosa cells
(Buarends et al., 1995). Similar to inhibin, AMH participates in primary follicle formation during
folliculogenesis by inhibiting excessive primordial follicular recruitment by FSH (Lee and Donahoe
1993; Durlinger et al., 1999). Currently, AMH is used as a marker of fertility in women (Weenen et
al., 2004), cattle (Ireland et al., 2008) and mice (Kevenaar et al., 2006), with circulating concentration
being positively correlated with the number of morphologically healthy oocytes within the follicular
reserve (Ficicioglu et al., 2006; Visser et al., 2006). Clinically, tests for AMH commonly are used to
estimate the onset of menopause in women, a state of reproductive cycle cessation due to ovarian
follicle depletion (Rock and Bartlett, 1937; van Rooij et al., 2002; van Rooij et al., 2005). To date,
AMH in the elephant has not been investigated.
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During the time when FSH and activin begin to decrease and estradiol and inhibin increase,
the first of two waves of follicular development is observed, along with subsequent estradiol and LH
surges (Hermes et al., 2000; Leuders et al., 2010). Although not completely understood, the elephant
experiences two LH surges during the follicular phase, 19-21 days apart, unlike the single LH surge
that is seen in all other mammalian species (Kapustin et al., 1996; Brown et al., 1999). The first LH
surge occurs 10-20 days after the drop in luteal progestagens and does not result in ovulation;
however, without this first LH surge ovulation during the second LH surge does not occur (Hermes et
al., 2000). During both anovulatory and ovulatory LH surges, concentrations of urinary estrogens
and serum LH reach about 8 ng/mg and 13 ng/ml, respectfully; thus, both surges are qualitatively and
quantitatively similar (Brown et al., 1999; Brown et al., 2004b). Although not completely
understood, the two LH surges could serve an evolutionary purpose because of the social structure of
the wild elephant. In the Asian elephant, a urinary pheromone, (Z)-7-dodecenyl acetate (Z7-12: Ac)
has been detected immediately after the anovulatory LH surge (Rasmussen, 2001). This pheromone
may be detected kilometers away by prospective males, allowing them approximately 21 days to
locate females that will soon be in estrus (Rasmussen, 2001). Such pheromones secreted in the urine
of the African elephant are yet to be identified.

Specifically for the African elephant, but not the Asian, the protein hormone prolactin
secreted from lactotrophic cells in the anterior pituitary is increased during the time of follicular
development (Brown and Lehnhardt, 1997). Prolactin is involved in a variety of biological processes,
most notably mammary gland development during mid to late gestation and postpartum lactation
(Rillema, 1994 and 1998). Prolactin release is under constant inhibitory control by dopamine
released from tubero-infundibular dopamine (TIDA) neurons in the arcuate nucleus of the
hypothalamus (Ben-Jonathan, 1994). Prolactin has been found to participate in a variety of
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physiological processes; several mechanisms of action for prolactin are of particular interest in
regards to reproduction and are dependent on species and stage of estrous cycle (Freeman et al.,
2000). In the rodent, prolactin is the main luteotropic hormone to ensure pregnancy survival via
maintenance of progesterone secretion from the corpus luteum (CL) by decreasing the progesterone
metabolizing enzyme 20α-hydroxysteroid dehydrogenase (Lamprecht et al., 1969; Bast and
Melampy, 1972; Morishige and Rothchild, 1974). Additionally, at the ovarian level, prolactin has
anti-atretic properties in preovulatory follicles in cattle (Lebedeva et al., 1998). In the African, but
not the Asian elephant, prolactin is shown to increase in a cyclic pattern during the follicular phase of
the estrous cycle (Brown et al., 2004; Yamamoto et al., 2010). Thus, in the African elephant,
prolactin could participate in follicular selection and development.
Prolactin secretion is under both positive and negative regulation. Hypothalamic dopamine
acts on specific membrane bound receptors, dopamine 2 (D2) receptors, on lactotrophs in the anterior
pituitary to inhibit prolactin synthesis by decreasing intracellular cyclic adenosine monophosphate
(cAMP), which is necessary for prolactin mRNA synthesis (Vallar and Meldolesi, 1989).
Additionally, melatonin from the pineal gland has also been identified as a prolactin inhibitory factor.
Working through a different physiological system than dopamine, melatonin acts to decrease the
synthesis of a prolactin-stimulating factor, namely vasoactive intestinal polypeptide (VIP) (Kamberi
et al., 1971; Nicosia et al., 1983).
Vasoactive intestinal polypeptide in the brain is synthesized in and secreted from two distinct
areas, the hypothalamus and lactotrophs in the anterior pituitary. Acting to stimulate prolactin
mRNA synthesis by enhancing adenyl cyclase and subsequently cAMP, directly at the lactotroph
and/or indirectly through deactivation of TIDA neurons, VIP works in concert with other prolactinstimulating factors (Ajika et al., 1972; Meites et al., 1972; Ben-Jonathan et al., 2008). Estrogen acts
on the hypothalamus to decrease dopaminergic tone and directly on lactotrophs to increase
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thyrotropin-releasing hormone (TRH) receptors and on D2 receptors to block the dopamine-induced
decrease in cAMP. In addition, TRH is known to increase prolactin production via direct stimulation
by calcium or the subsequent phosphorylation of proteins through a calmodulin-dependent protein
kinase (Tashjian et al., 1971; Geras et al., 1982). Furthermore, corticotrophin-releasing hormone
(CRH) has also been shown to stimulate prolactin secretion (Sar and Meites, 1968). Bechart and
colleagues (1999) found a negative correlation of progestagen and cortisol and a positive correlation
between prolactin and cortisol in the female African elephant. Moreover, an increase in circulating
cortisol concentration has been observed in non-cycling, hyperprolactinemic female African
elephants (Brown et al., 2004b). However, in the human, cortisol has a suppressive effect on the
prolactin gene and synthesis of prolactin (Molitch, 2009).

The first follicular wave yields 2-4 small follicles that grow to approximately 10 mm in
diameter before becoming atretic; no dominant follicle is observed during the first wave in the
cycling, non-pregnant African female elephant (Hermes et al., 2000). Two days before ovulation a
single antral follicle, ≥ 20 mm in diameter, derived from the second follicular wave will be the only
structure on the active ovary (Hermes et al., 2000; Leuders et al., 2010). Ovulation occurs between
18 and 24 hours after the ovulatory estrogen peak and subsequent LH surge. In contrast to the
negative feedback that estradiol exerts on tonic GnRH secretion during follicular development, the
estradiol surge resulting in ovulation works through the hypothalamic surge center in a positive
feedback loop; this mechanism is thought to work via a kiss-1 mediation of glutamate stimulation on
GnRH neurons (Smith et al., 2006). Interestingly, progestagens begin to rise one to three days before
the ovulatory LH surge (Kapustin et al., 1996; Brown et al., 1999). Although the rise in progestagen
concentration is considered a normally occurring event in both Asian and African elephants,
physiologically it is not yet understood.
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Luteal Phase

After ovulation of the dominant follicle, concentrations of progestagens and FSH begin to
increase, with FSH lagging behind progestagens by approximately one week (Brown et al., 1999a;
2004b). Increases in hormone concentrations occur regardless if the cow is pregnant or not, followed
by normal estrous cycle profiles for approximately eight weeks (Brown and Lehnhardt, 1995), after
which progestagen concentration will begin to decrease. However, if there is maternal recognition of
pregnancy then the CL will not regress and progestagen concentration will increase and remain
between 1.0 ng/ml to 1.5 ng/ml for the remainder of the 22 month gestation (Brown and Lehnhardt,
1995).

The 8-10 week luteal phase of the elephant is dominated by progestagens produced by the CL.
Unlike other eutherian mammals, the major circulating progestagen in the elephant is not
progesterone, but rather its 5-α reduced metabolites, 5α-pregnane-3, 20-dione (5α-DHP) and 5αpregnane-3-ol-20 one (5α-P-3-OH); 5α-DHP is the most prominent in blood serum (Hodges et al.,
1997; Schwarzenberg et al., 1997). In circulation, 5α-DHP follows a biphasic pattern, rising to a
concentration of 0.8-1.1 ng/ml midluteal and is maintained for approximately eight weeks before
falling to a baseline concentration of ≤0.08 ng/ml (Carden et al., 1998).
During the luteal phase, concentrations of FSH increase allowing for recruitment and growth
of follicles to occur, as well as participation in the production of estrogen via aromatase activation
(Brown et al., 1999a; 2004b). In the elephant, FSH increases during the same time that progestagen
is at its highest concentration; FSH reaches a plateau which is held at a constant concentration until
dropping prior to ovulation. In other monovular species such as horse (Bergfelt et al., 1991), cattle
(Kaneko et al., 1995), and primates (Schneyer et al., 2000; Zeleznik, 2001), FSH is shown to increase
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in spikes preceding each follicular wave, dropping to baseline concentration directly afterward
(Ginther et al., 2001). Interestingly, waves of follicular development are only observed during the
follicular phase after progestagen has decreased to baseline concentrations (Hermes et al., 2000). As
the luteal phase progresses, the CL begins to slowly regress and, thus, new estrogen producing
follicles are developing in two follicular waves (Hermes et al., 2000). Unless pregnancy is
established, this dynamic environment of the ovary sets the stage for the follicular phase and
subsequent ovulation.

The luteolytic mechanism in the elephant has not yet been characterized. In domestic animal
species as well as primates and humans, prostaglandin F2α (PGF2α) is the primary luteolytic hormone
initiating luteal regression. During the follicular phase, estradiol causes upregulation of endometrial
oxytocin receptors and progesterone during the luteal phase increases phospholipid stores and
synthesis of the enzyme prostaglandin synthase; both mechanisms support production of luteolytic
PGF2α (Pate and Townson, 1994). In the cow (Thatcher et al., 1976), sheep (McCracken et al.,
1972), and pig (Moeljonoet et al., 1977), pulsatile secretion of posterior pituitary oxytocin acts on the
uterine endometrium to stimulate the synthesis and pulsatile secretion of PGF2α; a finite store of
oxytocin in the CL acts to amplify PGF2α pulses from the uterus (McCracken et al., 1999).
Luteolytic concentration of PGF2α is transported to the ovary via a vascular countercurrent exchange
mechanism consisting of the utero-ovarian vein and ovarian artery (Ginther, 1974). In addition to
increasing oxytocin release, PGF2α binds at the ovary to specific receptors on the plasma membrane
of luteal cells (Fried et al., 1969). Prostaglandin F2α causes ischemia (Niswender et al., 1976),
activates protein kinase C to inhibit progestagen synthesis (Lahav et al., 1976; Davis et al., 1987),
stimulates an influx of immune cells (Webb et al., 2002) and increases intracellular calcium
(Dorflinger et al., 1984). These actions result in apoptosis of luteal cells and ultimately regression of
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the CL. Day of luteolysis is species specific (Diaz et al., 2007). However, Gross and colleagues
(1991) showed that administration of intramuscular injections of 80-125 mg PGF2α to cycling female
elephants 25, 30, 45, and 60 days post estrus failed to initiate luteolysis. Circulating serum
progestagen concentration decreased in one female four days after injection on day 60 of treatment;
however, luteal regression normally begins on day 60. Although it was concluded that PGF2α was
incapable of inducing luteolysis at this dose regimen for the female elephant, dose, number of
injections per animal per day, and route of injection play key roles in initiation of lyses of luteal cells
in other species. Therefore, further studies regarding the role of PGF2α in luteolysis in the elephant
are necessary.

Reproductive Abnormalities

Estrous Acyclicity

As documented by Brown et al., (2004a; 2004b) captive elephants in North America
experience ovarian inactivity, wherein the circulating progestagen concentration is held at baseline.
This phenomenon, termed acyclicity, has been observed in captive African and Asian elephants in
North America, as well as in European zoological facilities (Brown et al., 2004b; Oerke et al., 1999).
Acyclicity occurs specifically in older Asian elephants ≥ 40 years of age but throughout the postpubertal reproductive life of the African elephant; ≥11 years of age and older. Within North
American zoological facilities, approximately 11% of Asian and 31% of African elephants are
acyclic, with an additional 11% of Asian and 13% of African elephants exhibiting irregular estrous
cyclicity (Proctor et al., 2010). In addition, Hildebrandt and colleagues (2000) found that,
ultrasonographically, the vagina of acyclic cows shows an advanced dormant appearance wherein the
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vaginal mucosa is hyperechogenic. Interestingly, this condition seems to be reversible (Brown et al.,
2004b; Schulte et al., 2000).

Housing and Management

Housing conditions and management practices play a deciding role not only in longevity, but
also in reproductive success for other captive species. In captivity, the black rhinoceros (Diceros
biconis) exhibits high mortality and inconsistent reproductive rates. The captive population has not
been able to sustain itself without replacements from the wild (Smith and Reed, 1992). Furthermore,
mortality in this species has been positively correlated with time spent on exhibit in public access
areas, breeding success has been positively correlated with exhibit size, and zoological facilities
housing more than one female have seen a decrease in reproductive success (Carlstead et al., 1999a).
Furthermore, parallels exist between captive African elephants and black rhinoceros wherein both
captive populations are not self sustaining, with a failure of more than one-third of the captive
population to breed, long-birth intervals among multiparous females, and in most cases death rates
exceeding birth rates (Carlstead et al., 1999a and 1999b). For example, since 1999, there have been
37 recorded African elephant births and 42 deaths in North American at Association of Zoos and
Aquariums (AZA) accredited zoological facilities. Of the 37 births, 14 (37%) calves have already
died from disease and trauma related incidences (Olson, 2009). Miller-Schroeder and Paterson
(1989) found that enclosure volume, enclosure complexity, and availability of privacy were
positively correlated with breeding success in Western lowland gorillas (Gorilla gorilla gorilla).
Comparably, large enclosures and multiple nest boxes are important factors in successful
reproduction in the red panda (Ailurus fulgens) (Roberts, 1989). Clouded leopards (Neofelis
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nebulosa) experience increases in circulating cortisol concentrations in accordance to enclosure
height, degree of exposure to the public and/or predators, and type of keeper interactions
(Wielebnowski et al., 2002). Additionally, female cheetah (Acinonyx jubatus) housed together
experience ovarian suppression and display more behaviors indicative of potential distress; i.e.
stereotypic pacing and increased aggression (Brown et al., 1996). The findings of these studies
reaffirm that zoos should manage captive species according to natural history and natural social
conditions whenever possible.

Dietary Insufficiencies

Although captive elephants are free of dietary pressures seen in wild conspecifics, cases of
life threatening vitamin, mineral, and nutritional deficiencies within captive populations are
frequently documented. Reports of mineral deficiency diseases include rickets (Ensley et al., 1994),
zinc deficiency associated with foot and skin lesions (Schmidt, 1989), and vitamin E deficiencies
(Dierenfeld and Dolensek, 1988). In addition, obesity is an increasing problem in captive zoo
elephants thought to be due to a combination of an overly digestible diet and a lack of physical
activity; captive female African elephants are 27% heavier than wild females of the same age (Ange
et al., 2001). Not only does obesity have negative ramifications on animal care resulting in
atherosclerosis (Clauss et al., 2003b) and gastrointestinal problems (Salzert, 1976; Rüedi, 1995), but
also obesity could be directly correlated to estrous acyclicity. In human beings, obesity has been
linked to gonadal dysfunction, infertility, miscarriage, poor pregnancy outcome, impaired fetal wellbeing, cancer of the breast and uterus, and polycystic ovarian syndrome, in addition to diabetes
mellitus (Norman and Clark, 1998). Body weight has been shown to have an inverted “U” effect on
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reproduction; wherein low or high body mass contributes to infertility, menstrual disorders, and poor
reproductive outcome (Correa and Jacoby, 1978). Moreover, Freeman and colleagues (2009a) found
females with a larger body index were more susceptible to acyclicity.

Hyperprolactinemia

In 2004, Brown and colleagues completed a comprehensive study to determine if specific
hormonal imbalances were causative factors to ovarian acyclicity. Out of 10 hormones [LH, FSH,
prolactin, thyroid stimulating hormone (TSH), estradiol, free and total triiodide thyronine (T3), free
and total thyroxin (T4), and cortisol] that were assayed, significant differences were found in
circulating concentrations of estradiol, FSH, and prolactin in acyclic compared to normal cycling
females. Of particular interest, hyperprolactinemia was detected in one-third (11/33) of acyclic
African female elephants. In addition, for hyperprolactinemic females, estradiol was significantly
increased, FSH was significantly decreased and cortisol was increased, though not significant.
Comparably, Bechert and colleagues (1999) found a positive correlation between prolactin and
cortisol, and a negative correlation between progestagens and cortisol in female elephants. Although
prolactin is much needed during times of pregnancy and lactation to stimulate mammary
development and milk protein synthesis, continuously elevated concentrations of the hormone during
the menstrual cycle in human beings can contribute to infertility (Biller, 1999).

Hyperprolactinemia is one of the primary causes of amenorrhea and anovulation in the human
(Yu et al., 1981; Jones, 1989). Although hyperprolactinemia has been associated with sleep apnea,
anorexia, protein ingestion, hypoglycemia, stress, chest wall stimulation, and trauma (Woolf, 1986;
Jones, 1989; Biller et al., 1996), the three main causative factors of hyperprolactinemia resulting in
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infertility in the human are physiological (pregnancy and lactation); pharmacological (antiinflammatories, analgesics, and H2 inhibitors); and pathological (pituitary prolactinomas) (Mah and
Webster, 2002). High concentration of prolactin in pregnant or nursing individuals acts at the
hypothalamus to increase sensitivity to estrogen, which subsequently suppresses the GnRH/LH pulse
generator causing lactational amenorrhea (McNeilly, 2001). In addition, increases in serum prolactin
can also act via receptors on dopaminergic neurons resulting in an increase in dopamine release
(Moore and Demarest, 1982.). Dopamine not only acts to inhibit anterior pituitary prolactin synthesis
and secretion, but also decreases gonadotropin synthesis and secretion indirectly by suppressing
GnRH secretion in the hypothalamus causing gonadal dysfunction (Rolland and Corbey, 1977). In
the human, a variety of pharmaceuticals either work as receptor antagonists to remove dopamine
inhibition or directly stimulate prolactin secretion, both of which result in a dramatic increase in
prolactin secretion (La Torre and Falorni, 2007). Regardless of causative pathway, an increase in
prolactin secretion would cause an increase in dopamine resulting in suppression of GnRH.
Prolactinomas account for 25-30% of functioning pituitary tumors and are a major contributor to
hyperprolactinemia (Webster and Scanlon, 1997). Not only could tumors in the pituitary cause an
abnormal increase in prolactin secretion and subsequent dopamine release, but tumor presence could
physically block the secretion of gonadotropins thereby compromising estrous cyclicity (Mah and
Webster, 2002). Likewise, tumor growth could result in release of other pituitary derived hormones
causing perturbations in the hypothalamic-pituitary-ovarian/adrenal axis resulting in infertility
(Webster and Scanlon, 1997). Adenoma in a Western lowland gorilla (Gorilla gorilla gorilla) has
been shown to cause hyperprolactinemia resulting in gonadal dysfunction (Chatfield et al., 2006).
Furthermore, pharmacologically-induced hyperprolactinemia in the rat caused a decrease in core
body temperature, increase in circulating corticosterone and a decrease in pituitary
adrenocorticotropic hormone (ACTH) (Drago and Amir, 1984; Drago et al., 1989). Although
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prolactin concentration during pregnancy and lactation in elephants has been studied (McNeilly et al.,
1983; Brown and Lehnhardt, 1997), the contribution of pharmaceuticals and pituitary tumors on
hyperprolactinemia in the elephant is yet to be investigated.

Prolactin Deficiency
Prolactin deficiency has been associated with menstrual disorders, delayed puberty, infertility,
and subfertility in humans (Martikainen et al., 1989; Falk, 1992; Mukherjee et al., 2003; Van Aken
and Lamberts, 2005). Although the mechanism of action remains unknown, in the majority of
prolactin deficient cases, the actual deficiency is a secondary condition to general anterior pituitary
dysfunction (Toledano et al., 2007). The clinical signs of prolactin deficiency are dependent on the
extent of the deficiency and may be non-specific. In humans, prolactin deficiency often occurs in
conjunction with other pituitary hormone deficiencies, head injury, infections, and parasellar or
infiltrative disease (Roberts and Ladenson, 2004; Van Aken and Lamberts, 2005). In addition,
several pharmaceuticals, i.e., pyridoxine, hydergine, and diuretics, have been identified as inhibitors
of prolactin synthesis (Yazigi et al., 1997).
It is well documented that prolactin deficiency in the horse via Tall Fescue Toxicosis has been
directly linked to numerous reproductive problems such as extended gestation periods, abortion,
increased incidences of stillborns and dystocia, and decreased lactation (Cross et al., 1999). Tall
fescue infected with an endophytic fungus, Neotyphodium coenophialium, contains ergot alkaloids
that act as a dopamine D2 receptor agonist (Oliver, 1997). Such agonists have a direct inhibitory
effect on lactotroph cells in the anterior pituitary suppressing prolactin synthesis (Macleod and
Lehmeyer, 1974). Supplementation in mares (Evans et al., 1999) and heifers (Evans et al., 2003)
with dopamine D2 receptor antagonist domperidone has been successful to counteract the deleterious
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effects on reproduction during ergot alkaloid ingestion. Interpretation of these data suggests
reinitiation of prolactin synthesis may be needed for normal reproductive function.
In a 1988 study using human in vitro fertilization patients, treatment with the dopamine
agonist bromocriptine after ovarian hyperstimulation resulted in decreased serum and follicular fluid
prolactin, increased serum estradiol, accelerated ovarian follicle growth, decreased luteal phase
progesterone concentration, and subsequently shortened luteal phase length, thus, suggesting that
induced hypoprolactinemia interferes with ovarian function (Kauppila et al., 1988). Furthermore,
prolactin has gonadotropic activity (Doppler, 1994; Wise and Maurer, 1994; Lebedeva et al., 1998)
and has been implicated in the regulation of ovarian function in a number of species (Gaytan et al.,
1997; Clarke and Cummings, 1989). Prolactin increases during the follicular phase of the estrous
cycle in response to positive feedback action of follicular estrogens on the pituitary lactotroph cells
(Lawson et al., 1993) and acts on specific ovarian receptors to regulate follicular activity (Besognet et
al., 1996; Besognet et al., 1997). In addition, healthy follicles contain significantly higher follicular
fluid prolactin concentrations than atretic ones (Lebedeva et al. 1998). Follicular fluid prolactin is
believed to be involved in angiogenesis and the stimulation of ovarian epithelial cells, both of which
are important for follicular formation of corpora lutea (Castilla et al., 2010). Prolactin in conjunction
with gonadotropins and estradiol, aids in the process of oocyte maturation by inhibiting the
degeneration of surface epithelial cells and the disruption of connective tissue in the follicle wall.
Thus, high preovulatory concentrations of prolactin may be important to the process of follicular
growth, oocyte maturation and ovulation (Yoshimura et al., 1991).
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Interactions with Herd Members

Certainly, interaction with herd mates could play a role in reproductive acyclicity. In a
variety of species, including gray wolves (Canis lupus) (Packard et al., 1985), cheetah (Acinonyx
jubatus) (Wielebnowski et al., 2002), dwarf mongoose (Helogale parvula) (Creel et al., 1992),
African wild dog (Lycaon pictus) (Creel et al., 1997), black-backed jackal (Canis mesomelas) (Creel
and Creel, 1991), naked mole-rats (Heterocephalus glaber) (Faulkes et al., 1990; Smith et al., 1997),
saddle-back tamarin (Saguinus fuscicollis) (Epple and Katz, 1984), and marmoset monkey
(Callithrax jacchus) (Abbott, 1984) estrus suppression is a common occurrence wherein the dominant
female will suppress reproductive cyclicity in subordinates via direct contact, vocal or chemical cues.
In wild elephant herds, during times of drought when resources are sparse, the matriarch may actually
suppress reproduction in younger subordinate females (Sikes, 1971; Dublin, 1983). For the elephant,
the role of dominance status of captive females has recently been investigated by Proctor and
colleagues (2010b). Utilizing behavioral surveys completed by elephant keepers, observations, and
endocrine data, investigators suggested that the cow that assumes the matriarchal role among captive
family groups experiences an increase in reproductive acyclicity. It is hypothesized that because
captive groups consist of non-related females continuously moved to different facilities throughout
their lives, which is in direct contrast to wild herds, much more energy is spent maintaining peace
among herd mates, and maintaining dominant status (Freeman et al., 2009a and 2010). In wild
conspecifics, more female to female competition has been observed during times when resources are
limited, whether those resources be food, water, or mates (Schulte et al., 2000; Slade et al., 2003;
Archie et al, 2006).
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Stress

Suppression of reproduction in subordinates could possibly be accomplished via stressmediated alteration to the hypothalamic-pituitary-adrenal (HPA) or hypothalamic-pituitary-ovarian
(HPO) axis, thus resulting in ovarian inactivity. Reproduction in the nonpregnant female is
dependent on a carefully synchronized sequence of endocrine events. Adrenal-produced cortisol
secreted during times of stress is a known suppressor of GnRH from the hypothalamus (Ringstrom
and Shwartz, 1987). Increased glucocorticoid secretion near the onset of estrus in the cow, ewe, and
sow can block the ovulatory surge in LH and ovarian steroidogenesis (Essawy et al., 1989), suppress
PGF2α subsequently prolonging the estrous cycle in ruminants (Abilay et al., 1975; Liptrap, 1993),
and retard follicular development at the time of emergence of the ovulatory cohort in the sow
(Liptrap, 1970; Barb et al., 1982). During the normal estrous cycle, GnRH from the hypothalamus
acts at the pituitary level to initiate the secretion of gonadotropins, FSH and LH. Once in circulation,
FSH and LH target granulosa and thecal cells, respectively, in the developing follicle. If GnRH is
suppressed via cortisol, then FSH and LH are also subsequently suppressed, not only blocking
ovulation but also follicle selection and development (Moberg, 1985). Blood cortisol analysis has
proven useful as an indicator of stress under a variety of conditions wherein not all events were
considered negative (Elridge et al., 1976; Line et al., 1987; Reinhardt et al., 1990). However, cortisol
clearly is not sensitive to every type of stressor, and considerable intra-animal variability in biological
responses exists.
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Environmental Factors

Environmental changes deviating from the norm are also factors that can cause alterations in
ovarian activity. For a variety of mammalian species, multiple environmental factors play key roles
in reproduction, such as resource availability, ambient temperature, rainfall, day/night cycle, and
social cues (Bronson, 1985). Although the elephant is not a classical seasonal breeder, whereby
breeding cyclicity and subsequent receptivity is initiated by photoperiod, breeding activity increases
in the wild African elephant during times of increased rainfall when resources are most abundant
(Asdell, 1964; Sadleir, 1969). One particular study investigating if environment played a role in
reproductive cyclicity in three captive African cows in Rhode Island, North America, showed a
positive correlation of acyclicity with time spent indoors. Importantly, the most time spent indoors
was during the winter (Schulte et al, 2000). Moreover, data from the North American African
Elephant Studbook and 2005 Reproductive Assessment Survey show, regardless of time of year or
location of facility, elephants remain cyclic and are capable of breeding 365 days a year (Olsen,
2009; Proctor et al., 2010a).

Age

Reproductive cessationincreasing with age is common among long-lived species. As a female
continues to cycle, follicles are selected for development either resulting in atresia or ovulation.
Throughout a female’s reproductive lifespan, follicular reserves are continually reduced until finally
not enough follicles remain to produce the necessary hormones to support cyclicity (Richardson et
al., 1987). The elephant in the wild spends her post-pubertal life either pregnant or in lactational
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anestrous. With a 22 month gestation and a four to six year calving interval, a cow that lives well
into her 50s could have only 10 breeding opportunities throughout her entire life time. Wild cows
well into their 50s, have successfully given birth to healthy calves; however, there are also cows that
seem to stop showing signs of estrus as early as her 40s (Laws et al., 1969; Hall-Martin, 1987;
Whitehouse and Hall-Martin, 2000; Moss, 2001). The latter is thought not to be due to a known
depletion of her follicular reserves, but instead due to the grandmother hypothesis (Hawkes et al.,
1998; Alvarez, 2000; Hawkes, 2004). Rather than continue to use energy reserves to give birth
herself, older females are known to care for other calves in the herd. This kind of nurturing allows
the calf’s mother to conserve her energy ensuring that she remains healthy and able to produce milk
of the highest nutrient content to maintain good calf health. Furthermore, this kind of aid from older
females can enable other mothers to wean offspring sooner thus increasing reproductive rates
(Hawkes, 2004). In contrast, elephants in captivity do not have the breeding opportunities that their
wild counterparts experience. Data collected from a recent reproductive assessment survey showed
that only 45.9% of Asian and 42.6% of African elephants in North America have either experienced a
natural breeding via direct contact with a bull or breeding via artificial insemination. Moreover, of
those cows with breeding histories, 61.5% of Asian and 76.6% of African cows became pregnant and
68.7% of Asian and 39.1% of African females delivered a live calf (Olsen, 2009; Proctor et al.,
2010a). With a 16 week estrous cycle, captive cows can have approximately three cycles per year.
Although the average lifespan of a captive elephant is much shorter than wild females, 29.8 years
compared to 56.0 years, captive elephants with no breeding history could cycle at least 60 times in
their lifespan, a six-fold increase (Clubb et al., 2008 and 2009; Olsen, 2009). It is possible the
constant cyclicity could lead to a premature cessation of estrous cycles due to earlier threshold
follicle depletion.
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Reproductive Tract Pathologies

Over the last 10 years, incidences of reproductive tract pathologies such as tumors and polyps,
cysts, and endometrial disease appear to be increasing in captive African female elephants (Hermes et
al., 2004). As of 2008, 37.5% (27/72) of captive reproductive age female African elephants
monitored in North America via transrectal ultrasonography were affected with at least one
reproductive tract pathology (Proctor et al., 2010a). In comparison, data from wild culled African
elephants revealed that reproductive tract pathologies in general only occurred in 3.3% (18 out of
552) reproductive age females. Furthermore, only 9.4% (n=112) of reproductive age females
appeared to be experiencing a loss of ovarian activity as determined by a lack of structures on the
ovary, i.e., follicle(s) of any stage of development or CL. Interestingly, only one female, a 58-yearold cow, had never calved (Freeman et al., 2009b).

Tumors and polyps in the reproductive tract can be detrimental to reproductive success. The
anatomy of the female elephant is unique wherein the urogenital tract opening is located on the
abdomen between the rear legs; total tract length is approximately 12 feet (Balke et al., 1988).
Obstruction of the tract in the vestibule, vagina, cervix, or uterus by a benign tumor could cause pain
and discomfort during mating or act as a physical barrier preventing sperm from traveling into the
oviduct for ovum fertilization (Hildebrandt et al., 2000a). Furthermore, passage of the blastocyst
from the oviduct into the uterine body could be compromised, as well as implantation and
placentation (Perry, 1974). Although such pathologies have never been found in the African elephant,
Asian elephants experience benign smooth muscle fibroid tumors known as uterine leiomyomas
(Hildebrandt et al., 2000a). Growth factors and steroid hormones play a key role in the development
of leiomyomas (Marsh and Bulun, 2006). First described in 1793 by Baillie, uterine leiomyomas are
the most common mass found in women in a clinical setting, becoming more prevalent with age and
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reproductive experience; 40% of woman over 40 years of age experience leiomyomas (Buttram,
1986). Montali and colleagues (1997) found similar results in aged, nulliparous female Asian
elephants. Although uterine fibroids are estrogen and progestagen dependent, individuals suffering
from this pathology do not always experience abnormal circulating concentration of steroid hormones
(Hildebrandt and Göritz, 1995). However, fibroids contain an increased number of receptors for
estrogen and progesterone (Marsh and Bulun, 2006).

Despite extensive research regarding ovarian cysts, an exact etiology remains unknown. In
the human, polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders
compromising fertility. Woman with PCOS exhibit abnormally high circulating androgen
concentration and peripheral insulin resistance; there has also been a link to obesity (Ehrmann, 2005).
Although a treatment protocol for PCOS including weight loss, exogenous hormone therapy via birth
control pills, aromatase inhibitors, LH analogs, and Metformin, a hypoglycemia-inducing drug that
increases insulin sensitivity, has shown success in regaining fertility, no definitive treatment has been
agreed upon (Badawy and Elnashar, 2011). In cattle, cystic ovarian disease involves follicular cysts,
luteinized follicular cysts, or cystic CL (Roberts, 1971; Bierschwal et al., 1975). Furthermore,
abnormal estrous behavior from perturbations within the endocrine environment results in either
constant estrus or anestrus (Casida et al., 1944; Garm, 1949). Treatment in this species is most often
accomplished through exogenous administration of GnRH. A study by Cantley and colleagues
(1975) showed that approximately 80% of cystic cows treated with GnRH recovered and resumed
cyclicity within 23 days. Ovarian cysts are observed in approximately 15% of captive African
elephants, but are rarely observed in their wild counterparts with a documented incidence of <1% in
data collected from natural deaths and culls (Hildebrandt et al., 2004; Freeman et al., 2009b).
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Treatment with exogenous GnRH of one African female, 23 years of age, presenting a reoccurring
ovarian cyst did not elicit a response (Brown et al., 1999b).

In the rhesus monkey (macaca mulatta) (Zuckerman, 1937), Boer goat (capra hircus) (Radi,
2005), Vietnamese pot-bellied pig (Sus scrofa) (Harmon et al., 2004), domestic dog (Canis
familiaris) (Bosschere et al., 2000), and peri-menopausal human (Takreem et al., 2009), cystic
endometrial hyperplasia (CEH), a progressive degenerative disorder of the endometrium, has been
observed to impair fertility. In Asian and African elephants CEH has been shown to occur more
frequently and be more prevalent in aged, nulliparous females. Moreover, CEH lesions are severe
and associated with polyps (Agnew et al., 2004). Unlike other species with CEH, elephants are
unique in that affected individuals have a normal hormonal environment; therefore, CEH is not due to
exogenous phytoestrogens or ovarian estrogen-secreting cysts or tumors as in the sow, cow and ewe
(Kennedy et al., 1998, Agnew et al., 2004). Regardless, persistent CEH can cause infertility by
preventing implantation or fertilization. Similar to the carnivore, the elephant placenta is
endotheliochorial and zonary with uniform number and thickness of endometrial glands (Mossman,
1987). In the carnivore, size, number, and secretory function of endometrial glands are under
estrogenic and progestational influence, respectively (Ambrósio et al., 2011). Cyclicity i.e.,
progressive proliferation and prolonged secretory activity by the uterus, without pregnancy
interference can result in chronic proliferative changes in the endometrium. Interestingly, uterine
glandular hyperplasia in the adult mouse, rabbit and pig is caused by hyperprolactinemia (Chilton et
al., 1988; Young et al., 1989; Kelly et al., 1997).
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Statement of Problem

In a 2000 report, State of the North American African Elephant Population and Projection for
the Future, Olsen and Wiese concluded that “the current population may be able to become selfsustaining without the need of future importations only if reproduction and juvenile survivorship
increase significantly by 2010.” Currently, the North American captive population of African
elephants is not self-sustaining (Proctor et al., 2010a). Since 1999, there have been 37 documented
births (14 of which have already died) and 42 deaths; infant mortality, including infanticide continues
to increase (Clubb et al., 2008 and 2009; Olson, 2009). Moreover, data from the most recent
Reproductive Assessment Survey has shown estrous cycle abnormalities, as well as reproductive tract
pathologies continue to plague captive African elephants (Proctor at el., 2010a). Ten years ago there
was a growing concern among captive elephant managers that some of the behavioral problems
demonstrated by North American elephants are directly attributed to a lack of social learning and a
strong matriarchal figure. Captive “herds” consist of approximately two to three, same-aged animals
with no resemblance of the complex fission-fusion society that wild elephants have evolved (Olson
and Wiese, 2000). Therefore, the present studies are conducted to assess the frequency and
demographics of acyclic captive females, identify factors contributing to acyclicity, and development
of protocoles to restore estrous cyclicity in acyclic individuals. Although a substantial amount of
data has been gathered to help identify those factors contributing to acyclicity in this species, there
are a number of possible causes that are yet to be investigated (Figure 1).
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Abstract
A written survey assessed reproductive status of female Asian and African elephants in AZA/SSP
facilities in 2008, and data were compared to surveys conducted in 2002 and 2005. Results showed
ovarian acyclicity rates across the surveys remained unchanged for Asian (13.3, 10.9 and 11.1%) and
African (22.1, 31.2 and 30.5%) elephants, respectively (P>0.05), but were higher overall for African
compared to Asian elephants (P<0.05). In 2008, the percentages of Asian and African elephants with
irregular cycles (14.3 and 15.8%) and irregular + no cycles (25.4 and 46.4%) was similar to 2005 (7.6
and 11.8%; 18.5 and 43.0%), but were increased compared to 2002 (2.6 and 5.2%; 16.0 and 27.3%),
respectively (P<0.05). For both species, ovarian acyclicity increased with age (P<0.05).
Reproductive tract pathologies did not account for the majority of acyclicity, although rates were
higher in noncycling females (P<0.05). Bull presence was associated with increased cyclicity rates
(P<0.05) for Asian (92.5 versus 58.3%) and African (64.9 versus 57.8%) elephants compared to
females at facilities with no male, respectively. Cyclicity rates were higher for Asian (86.8 versus
65.2%) and African (67.9 versus 56.7%) elephants managed in free compared to protected contact
programs (P<0.05), respectively. Geographical facility location had no effect on cyclicity (P>0.05).
In summary, incidence of ovarian cycle problems continues to predominantly affect African
elephants. Although percentages of acyclicity did not increase between 2005 and 2008, 42.2% Asian
and 30.2% African females were no longer being hormonally monitored; thus, reproductive cycle
abnormalities could be worse than current data suggest.
Keywords: ovarian cyclicity, hormones, reproduction, acyclicity, ultrasound, progestagens
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Introduction
North American populations of elephants continue to be non-self-sustaining. Studbook data
show that in the last 10 years (1998-2008), Asian (Elephas maximus) and African (Loxodonta
africana) elephants averaged 4.0 and 3.7 births compared to 6.0 and 4.0 deaths per year, respectively.
Of the 77 calves born during this time, only 41 (53.2%) are currently still living [Keele et al., 2007;
Olson, 2008]. Furthermore, at present, 68.1% of Asian and 30.3% of African elephant populations
are considered post-reproductive; i.e., ≥ 35 years old. It has been hypothesized that if reproductive
rates are not increased significantly, the North American elephant populations will become
demographically extinct within a few decades [Olsen and Wiese, 2000; Faust et al., 2006; Wiese and
Willis, 2006].
To address this problem, the Association of Zoos and Aquariums (AZA) Elephant Taxon
Advisory Group (TAG)/Species Survival Plan (SSP) takes steps to ensure females between 11 and 35
years of age are given every opportunity to breed. Hormone profiling services, specifically for
progestagens in frequent blood, urine, and/or fecal samples are provided by several laboratories in the
U.S., including the Smithsonian Conservation Biology Institute (SCBI). Data from these laboratories
have been instrumental in assessing elephant fertility status for TAG/SSP breeding recommendations,
in addition to exposing a range of ovarian cycle problems, from irregular to chronically acyclic
[Brown et al., 1991; Brown, 2000; Schulte et al., 2000]. To document changes in reproductive
health, written survey data are being collected by our laboratory about every 3 years. The first was
conducted in 2002 [Brown et al., 2004], with a follow up survey in 2005 [Proctor et al., 2010]. These
surveys document: 1) how many females in the captive population are being hormonally monitored;
2) rates of ovarian cyclicity problems; 3) changes in the cyclicity status of individual females; 4)
what types of reproductive tract pathologies exist; and 5) relationships between age, reproductive
tract pathologies and ovarian problems. A comparison of the 2002 and 2005 surveys was
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discouraging because it showed a significant increase in ovarian and reproductive tract pathologies
within a 3-year period, particularly in African elephants (30.7% to 41.1% and 19.6% to 28.6%,
respectively) [Proctor et al., 2010]. The objective of this third survey was to determine if further
changes in the SSP populations have occurred. Additionally, a range of new variables including
management style, breeding history, male presence and facility location were analyzed to ascertain
possible contributions to estrous cyclicity status.

Materials and Methods
Written surveys were sent to all 76 AZA elephant-holding facilities in 2008, similar to
previous studies [Brown et al., 2004; Proctor et al., 2010]. Survey questions included those on herd
dynamics and demographics, facility location and climate, management system, reproductive
cyclicity status, transrectal reproductive tract ultrasound data, and breeding history over the past 15
years. Hormone cyclicity status referred to progestagen data subsequent to the survey completed in
2005 (i.e., a 3-year period). Ovarian cyclicity data were only used if a female had been assessed for
at least 1 year. Animal age refers to the age in 2008. Pregnant cows (2 Asian and 2 African) were
excluded from the survey results and analyses.

Statistical Analysis
Effect of categorical variables on cyclicity status, such as species (Asian, African),
management (free contact, protected contact, both), female social status within the herd (dominant,
middle, subordinate, variable), reproductive tract pathologies (undetermined, pathologies present,
normal morphology), presence of male in facility (yes, no), type of breeding (natural, artificial
insemination - AI, both, none), geographical location (average winter temperature below 3.9°C,
between 4.4 and 9.4°C, between 10 and 15°C, and above 15.6°C), years at a given facility, and age
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were determined using PROC GLM of Statistical Analyses System, version 9.1.3 (SAS Institute Inc.,
Cary, NC, 2004). Each of the variables was analyzed individually, then as the interaction within
species. Last, an overall model to predict cyclicity status was determined using all categorical data.
PROC ANOVA was used to determine the means and standard deviations for each variable and the
interactions. Significance was set at P<0.05. All data are presented as means ± SEM.

Results
Seventy-five of the 76 facilities in the Elephant SSP program participated in the 2008 survey.
Of those, 29 housed Asian elephants, 37 housed African elephants, and 9 housed both species. There
were 109 Asian and 136 African female elephants surveyed. Overall survey results are presented in
Table 1. A higher percentage of African than Asian elephants were monitored for reproductive
cyclicity via progestagen assessments (P<0.05). Of those females, African elephants exhibited a
higher rate of ovarian acyclicity as compared to Asian elephants (P<0.05). Additionally, African
females also experienced more irregular ovarian cyclic activity than did Asian females (P<0.05)
(Table 1).
The age range for the captive female Asian elephant population was 1-68 years, with an
average age of 34.5 ± 1.4 years. The age of captive female African elephants ranged from 1-53
years, with an average age of 28.1 ± 0.9 years. Overall, the African population was younger than the
Asian population (P<0.05). For both species, rates of acyclicity increased with age (P<0.05).
Reproductive cyclicity status data for both species as a function of age are summarized in Tables 2
and 3. Most acyclicity in postpubertal Asian elephants was observed in the older age group, those
aged >36 years (Table 2). For African elephants, acyclicity was observed in cows as young as 21
years of age, with the majority of acyclic females found in the 26-30 age category (Table 3). The
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vast majority (86.2%, 25 out of 29) of acyclic African elephants were between the ages of 26 and 40
years.
Reproductive tract ultrasound assessments were conducted on 56.9% (62 out of 109) of the
Asian and 46.3% (63 out of 136) of the African SSP elephants (Tables 4 and 5, respectively). There
were a number of females (7 Asian and 3 African) that had ultrasound results, but no corresponding
hormone data. For Asian elephants, 53.2% (33 out of 62) of females being hormonally monitored
had normal tract morphology. Twenty-nine Asian elephants exhibited at least one reproductive tract
pathology, but there was no difference (P>0.05) between females with tract pathologies that cycled
normally (n = 16) compared to individuals that exhibited irregular or no cyclicity (n = 9) (Table 4).
For African elephants, 71.4 % (45 out of 63) of those monitored had normal tract morphologies.
Eighteen African females possessed at least one reproductive tract pathology; more females with tract
pathologies exhibited irregular or no cyclicity (n = 11) compared to those that cycled normally (n =
5) (P<0.05) (Table 5). Overall, reproductive tract pathologies were observed in Asian females ≥15
years of age and African females ≥21 years of age (data not shown). The most prominent tract
pathologies were uterine cysts/tumors (31.1%) and other pathologies, i.e., idiopathic lesions,
leiomyomas, etc., (17.2%) for Asian (Tables 4), and vaginal cysts/tumors (22.2%) and other
pathologies (27.8%) for African (Table 5) elephants.
Breeding histories over the previous 15 years were obtained for 50 Asian elephants. Of 29
AIs reported, 10 resulted in a pregnancy. Of these, three were aborted, one fetus died in utero, four
resulted in live births, and two pregnancies were pending at the time of the survey. For 127 natural
matings, 46 were unsuccessful, four resulted in abortions, three were stillbirths, one fetus died in
utero, 34 resulted in live births, and four pregnancies were pending. Likewise, over the last 15 years,
Fifty-eight African females had 174 breeding opportunities; 63 by AI and 111 by natural mating. Of
the AIs, 47 were unsuccessful, two resulted in stillbirths, two fetuses died in utero, there were eight
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live births, and four were pregnant. For the 111 natural matings, 96 were unsuccessful, two fetuses
died in utero, there were 11 live births, and two pregnancies were pending. Conception rates for AI
(34.4% versus 25.4%) and natural matings (29.9% versus 13.5%) were higher (P<0.05) in Asian than
African elephants, respectively. Overall conception rates for Asian and African elephants were
30.8% and 17.8%, respectively. Females with breeding histories, whether successful or not, had a
higher rate of cyclicity (>75%) when compared to those females that had not been bred (51%)
(P<0.05).
Of the 75 SSP facilities surveyed, there were 25 African (n = 15 zoos) and 27 Asian (n = 15
zoos) bull elephants aged <1 to 45 years. A total of 124 females (67 African; 57 Asian) were housed
at a facility with a mature male, ≥ 15 years of age, compared to 69 African and 52 Asian elephants
that were not. For postpubertal Asian and African elephants, respectively, there was a higher ovarian
cyclicity rate (92.5% and 64.9%) among individuals housed at a zoo with a bull (P<0.05), as
compared to those zoos with no male (58.3% and 57.8%), whether there was direct contact or not.
For both species, geographic location and average daily winter temperature did not affect cyclicity
status in female elephants (P>0.05).
There were three types of management systems reported in the survey: free contact (n = 13
Asian, 13 African facilities); protected contact (n = 16 Asian, 25 African), and a combination of both
(n = 4 Asian, 4 African). Numbers of elephants managed using a combination of both were low;
however, ovarian cyclicity rates were highest at those facilities (93.1% of Asian and 70.0% of
African females cycled normally) when compared to those in protected contact only (65.2% for Asian
and 56.7% for African) (P<0.05). In facilities that used only free contact management, 86.8% of
Asian and 67.9% of African females cycled normally, which was higher than that for elephants in
protected contact (P<0.05).
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A total of 163 out of 236 female elephants (n = 64 Asian, 99 African) had both hormonal and
herd social status data. Elephants were characterized as having dominant, middle, subordinate, or
variable status according to keeper staff rankings. The majority of both Asian (50.1%) and African
(51.3%) females were considered to be of middle status within the herd hierarchy. For both species
there were no significant differences between herd status groups and ovarian cyclic activity (data not
shown).
An overall comparison of selected results between the 2002, 2005 and 2008 surveys is shown
in Table 6; significant differences among the three surveys are highlighted. There was a decrease in
the number of Asian elephants monitored in 2008 when compared to 2005 (P<0.05) due to older
individuals no longer being monitored. The percentage of Asian elephants with irregular cycles in
2008 was similar to that in 2005, but increased since 2002 (P<0.05). Likewise, there was no change
in the percentage of African elephants with irregular cycles between the 2005 and 2008 surveys
(P>0.05), but there was an increase between 2002 and 2008 (P<0.05). When acyclicity and irregular
cycling data were combined, the overall percentage of postpubertal individuals with abnormal
reproductive cycles was stable for Asian elephants, but increased for African females between 2002
and 2005 (P<0.05), with no further change in 2008 (P>0.05).
Between 2005 and 2008, nine Asian and 38 African females were new to the survey. Of
those, only two Asian females were being monitored with none cycling; 17 African females were
monitored with 13 listed as cycling. Of the returning females, 12 Asian and 10 African females not
monitored in 2005 were in 2008, with 1 and 4 females found to be not cycling, respectively. Several
females switched cyclicity status between the 2005 and 2008 surveys. For Asian elephants, one
irregular cycling female began to cycle normally (age 38 years), one switched from irregular cycling
to acyclic (age 42 years), seven cycling females became irregular (ages 28, 33, 36, 38, 40, and 50
years), four cycling females became acyclic (ages 28, 37, and 41 years), and eight acyclic and two

38

irregular cycling females were no longer monitored. For African elephants, although two new
females were being monitored, overall 26 fewer elephants had hormonal data in 2008 than in 2005.
Two irregular cycling females became acyclic (both 28 years old), two irregular cycling females
started cycling normally (ages 23 and 28 years), four acyclic females were irregular (ages 30, 38 and
39 years), two acyclic females switched to normal cyclicity (ages 22 and 25 years), 10 previously
cycling females were acyclic (ages 24 to 49 years), and seven acyclic and three irregular females
(ages ≥ 30 years) were no longer being hormonally monitored.
There was no difference in the percentage of individuals being monitored via transrectal
ultrasonography between Asian and African elephants, with only ~50.2% of the total SSP population
having previously been examined. For the 2008 survey, there was a decrease in the number of
reproductive age Asian females that were ultrasounded (P<0.05) when compared to 2002 and 2005;
however the total number was similar. For African elephants, the number of reproductive age
females in the population with ultrasound data remained unchanged across all three surveys, although
they represented a smaller portion of the population in 2008 than in 2002 and 2005.

Discussion
Supporting the results observed in 2002 and 2005, the 2008 survey showed that ovarian
acyclicity and reproductive tract pathologies continue to be a threat to the reproductive health status
of North American SSP populations of African and Asian elephants. Compared to 2002 data, there
was a 16.2% and 3.4% increase in tract pathologies, and a 9.4% and 19.1% increase in cyclicity
abnormalities in Asian and African elephants, respectively, in 2008. Ovarian cycle abnormalities and
reproductive tract pathologies are thus a continuing problem for both elephant species; however, the
African elephant appears to be more susceptible to fertility problems. When comparing the number
of reproductive age African females that were either acyclic or cycling irregularly, it appears that
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rates were stable between 2005 and 2008. However, closer evaluation of individual elephants
indicates this may not be the case. Of the 32 cows in 2005 with ovarian cycle abnormalities, 10
currently are no longer being monitored and six are now deceased. Furthermore, most of the 30
reproductive aged females reported as not cycling normally in 2008 have either switched from
cycling to noncycling or are new individuals to the survey. According to the recent age pyramid for
SSP African elephants [Olson, 2008], 103 females are < 35 years of age (i.e., considered potentially
reproductive). Of these, 73 (~70.1%) are hormonally monitored, with only 41 (32.3%) cycling
normally. Thus, acyclicity continues to be a major concern for this species, significantly reducing the
breeding population.
It was originally believed that elephant females were either cyclic or acyclic [Brown, 2000],
but now many Asian and African cows have been shown to alter between periods of normal cyclicity
and irregular or acyclicity during the prime reproductive years (11-35 years of age). Research over
the past 10 years have investigated possible causative factors for abnormal cyclicity, such as
seasonality [Bechart et al., 1999], herd rank and time spent outdoors [Schulte et al., 2000], and
behavioral influences of herd mates [Freeman et al., 2004, 2009, 2010]. Wild elephants are generally
not considered seasonal breeders, although fluctuations in estrus activity can occur during times of
climate change, i.e., drought and monsoon seasons [Douglas-Hamilton 1975; Moss 1983]. Increased
bouts of temporary ovarian inactivity have been reported in African elephants during winter months
when time spent indoors is increased [Schulte et al., 2000]. However, we found no differences
(P>0.05) in overall ovarian cyclicity rates in either species with respect to facility location, i.e.,
seasonal changes in temperature or precipitation. These findings confirm an earlier study that
showed no significant effect of facility location or climate on rates of ovarian acyclicity in zoo
African elephants [Freeman et al., 2009].
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Transrectal ultrasonography techniques have become instrumental in monitoring reproductive
tract health [Hildebrandt et al., 2003]. Currently, nearly half of the Asian and African populations
had an ultrasound examination conducted within the last 3 years. Of those, the majority exhibited
one or more of the following tract pathologies: ovarian, uterine, and vaginal cysts and/or tumors.
According to new data in 2008, more than half of all Asian and African cows with documented tract
pathologies had no previous breeding history either through natural mating or AI. Other studies have
shown that nulliparous cows >30 years of age have increased incidences of reproductive tract
pathologies, termed asymmetric reproductive aging [Hildebrandt et al., 2000; Hermes et al., 2004].
Older, nonreproductive African elephants are prone to developing endometrial hyperplasia
[Hildebrandt et al., 1997, 2000], whereas Asian elephants develop uterine leiomyomas [Hildebrandt
and Göritz, 1995; Hildebrandt et al., 2006], not unlike that observed in the present study. Overall,
individuals that experienced one or more breeding opportunities within the past 15 years cycled at a
rate 24.1% higher when compared to cows that had not been bred. More than likely, these results
reflect the biased selection of cycling females for breeding opportunities, which is now a requirement
of the Elephant TAG/SSP before a recommendation is approved.
A decade ago, Olsen and Wiese hypothesized that if reproductive rates were not increased 9fold, there would be few elephants in zoos by ~2050 [Olson and Wiese, 2000]. Although 2008
survey data showed that reproductive rates have increased, pregnancy loss and infant mortality also
are higher. Currently, only one-third of female Asian elephants are between 11 and 35 years of age
[Keele, 2007]. Of those, two-thirds had been given breeding opportunities, but less than one-third
conceived and carried a calf to full term [Doyle et al., 1999]. By contrast, almost three-fourths of the
African elephant population is between the ages of 11 and 35. Still, less than half had been bred,
either naturally or by AI, and only 10.0% actually conceived. Infant mortality, excluding stillborns,
over the last 10 years has claimed 1.7 juveniles per year for both species [Olson 2008]. Thus, not

41

only are low reproductive rates contributing to decreasing captive populations, but calf loss continues
to be a problem [Olson, 2008; Saragusty et al., 2009].
We speculated that the presence of a bull elephant might have a stimulatory effect on the
female estrous cycle, via chemical, visual, or auditory stimulation. This prediction was supported by
the 2008 survey data that showed the presence of a bull at a facility, whether in direct contact with
cows or not, significantly increased rates of estrous cyclicity by 37.0% in Asian and 10.9% in African
females. Male effects, both direct and indirect, on estrous cyclicity have been demonstrated in other
species. For example, in the female gray short-tailed opossum exposure to non-volatile male
pheromones in scent marks stimulated body growth, follicular development and estrous behavior
[Harder and Jackson, 2003]. Similarly, in cattle, indirect and direct bull exposure accelerated the
onset of puberty in heifers by ~74 days [Kinder et al., 1994]. And the presence of a male Angora
goat shortened the seasonal anestrous period in females by at least one estrous cycle [Shelton, 1960].
In elephants, chemical signals mediate intersexual and intrasexual interactions associated with
reproduction in both Asian and African elephants [Rasmussen and Schulte, 1998]. Bulls exude
chemical pheromonal signals from several orifices: the facial temporal gland, urine and breathe
[Rasmussen, 1998]. Asian elephant females are responsive to the urinary pheromone, frontalin,
depending on estrous state, and are most responsive during the follicular phase [Rasmussen and
Greenwood, 2003]. Still, there were a number of facilities with cycling females that did not house a
bull, and vice versa, so this is not an absolute requirement.
It has been previously shown that captive females who hold dominant herd status are more
prone to be acyclic [Freeman et al., 2004; Freeman et al., 2010]. But according to the 2008 survey
data, the majority of acyclic Asian and African elephants were ranked in the middle category. With
the current survey, herd status data was based on keeper rankings only, whereas work done by
Freeman and colleagues use more intensive behavioral and multi-question survey evaluation
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approaches. Thus, the lack of a relationship between social dominance and ovarian acyclicity in this
study could be methodological. Alternatively, given the large number of African females, throughout
all age categories, no longer being monitored, it is possible that more dominant, acyclic females no
longer are being included in survey data.
The impact of management style on ovarian activity also was investigated, which at present
consists of free contact, protected contact, or a combination of both. For both species, ovarian
cyclicity was higher in females housed in free or a combination of both free and protected contact
when compared to protected contact only. There was an average increase in the rate of ovarian
cyclicity of 24.9% for Asian and 12.5% for African elephants when individuals were in a
management program that incorporated direct human contact. Elephants are a very tactile animal,
and touching herd mates is a way of communication and reinforcing social bonds [Sukumar, 2003].
Thus, positive hands-on interactions in free contact could provide an enriching experience, both
mental and physical, for the elephants [Kahl and Santiapillai, 2004; Brown et al., 2008].
In summary, these data support efforts by the TAG/SSP to require SSP facilities to
continually monitor all reproductive aged females for reproductive tract health and hormone activity
[Keele and Ediger, 1997-2002]. This most recent survey showed that ovarian acyclicity, along with
reproductive tract pathologies, is evident among all postpubertal age groups for both African and
Asian elephants. Although overall rates of ovarian acyclicity did not change between 2005 and 2008,
irregular cycles continued to increase, and in many females represent the transition from a cyclic to
an acyclic state. Geographical location of a facility was not found to contribute to ovarian acyclicity,
whereas management style, male presence, breeding opportunities, age and presence of tract
pathologies all had significant influences on estrous cyclicity status in female elephants. There
continues to be a species difference in the types and degree of reproductive problems, with African
elephants apparently being more susceptible to factors affecting ovarian activity compared to Asian
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females. To ensure a healthy elephant population in North America, elephants must be selfsustaining. Continual longitudinal monitoring of ovarian steroids can identify changes in the
reproductive potential of the captive population, as well as in individual elephants. Now that we
know significant problems continue to exist, additional studies (i.e., diet, endocrine, physiological,
etc.) are planned to identify what are the contributing factors that inhibit ovarian function.

Conclusions
1. In 2008, 95/136 (69.8%) and 62/109 (56.9%) African elephants, and 63/109 (57.8%) and 63/136
(46.3%) Asian elephants were being monitored for hormone and ultrasound data, respectively.
2. Of those being hormonally monitored, acyclicity appears throughout all age groups of postpubertal African elephants, but most prevalent in older Asian elephants >35 years of age.
Currently 46.4% of African and 25.4% of Asian cows in SSP facilities experience some form of
ovarian cycle abnormality.
3. Reproductive tract pathologies such as ovarian, uterine, and vaginal cysts and/or tumors continue
to be observed in both Asian and African cows of all ages, with a 37.0% and 7.0% increase in
reproductive tract pathologies, respectively, over the last 6 years.
4. Management style, male presence, breeding opportunities, age and presence of tract pathologies
significantly impacted long-term reproductive health status in female elephants.
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TABLE 1. Response rates and cyclicity status results of the 2008 Reproductive
Assessment Survey for female Asian and African elephants in North America. Data are
for the SSP populations.
Asian
African
N
Percent
N
Percent
Studbook Population
220
190
SSP Population
114
136
Surveys Returned
109
95.6
136
100
No. Monitored1

68

62.4a

105

77.2b

Unknown + Not Monitored
Cyclicity Status

46

40.4a

31

22.8b

Cycling2

47

69.1a

51

48.6b

Irregular2

9

13.2

15

14.3

7
5

10.3a
7.4

29
10

27.6b
9.5

Not Cycling2
Immature
Unknown = no survey returned
1

Based on surveys returned from SSP facilities.
Numbers based on those monitored hormonally, and excludes females ≤ 10 years of age.

2

a,b

Superscripts denote significant difference (P<0.05) in cyclicity status between species

50

TABLE 2. Numbers and age distributions of Asian elephant females exhibiting normal ovarian cycles, no
ovarian cycles, or irregular cycles in the SSP population in North America based on 2008 Reproductive
Assessment Survey results.
Age of Asian Females in 2008 (years)
0 to 10

11 to 15

16 to 20

21 to 25

26 to 30

31 to 35

36 to 40

>40

5

9

4

9

6

15

26

35

5

9

4

9

6

14

26

34

No. Monitored

5

9

4

9

6

10

12

13

No. Cycling

0

9

4

9

4

7

5

9

No. Not Cycling

5

0

0

0

1

1

3

2

% Not Cyclingb

100

0

0

0

16.7

10

25

15.4

No. Irregular

0

0

0

0

1

2

4

2

No. Unknown & NM

0

0

0

0

0

5

14

22

% Unknown & NM

0

0

0

0

0

33.3

53.8

62.8

Total
Surveys Returned
a

Unknown = no survey returned, NM = not monitored hormonally.
a

Based on surveys returned for SSP facilities.

b

Percentages based on those monitored hormonally.
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TABLE 3. Numbers and age distributions of African elephant females exhibiting normal ovarian cycles, no
ovarian cycles, or irregular cycles in the SSP population in North America based on 2008 Reproductive
Assessment Survey results.
Age of African Females in 2008 (years)
0 to 10

11 to 15

16 to 20

21 to 25

26 to 30

31 to 35

36 to 40

>40

10

0

9

23

44

17

26

7

10

0

9

22

42

17

26

7

No. Monitored

10

0

8

18

36

12

18

3

No. Cycling

0

0

8

13

21

4

4

1

No. Not Cycling

10

0

0

2

11

7

7

2

% Not Cyclingb

100

0

0

11.1

30.6

58.3

38.9

66.7

No. Irregular

0

0

0

3

4

1

7

0

No. Unknown & NM

0

0

1

5

8

5

8

4

% Unknown & NM

0

0

11.1

21.7

18.2

29.4

30.8

57.1

Total
Surveys Returned
a

Unknown = no survey returned, NM = not monitored hormonally.
a

Based on surveys returned for SSP facilities.

b

Percentages based on those monitored hormonally.
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TABLE 4. Numbers of Asian elephants evaluated by transrectal
ultrasound, and categorized based on normal and abnormal urogenital
tract morphology within ovarian cyclicity status categories
Asian
Category
Normal

Cycling

Noncycling

Irregular

Not Monitored

27a

0b

3b

3

OC

1

UT c/t

6

VA c/t

4

1
1

1

OC, UT c/t, VA c/t

1

1

UT c/t, VA c/t

1

OP

1

OC, OP

1

UT c/t, OP

2

2
2

1

1

1

UT c/t, VA c/t, OP

1

NM = Not monitored hormonally, OC = Ovarian Cysts, UT c/t = Uterine
Cysts/Tumors, VA c/t = Vaginal Cysts/Tumors, OP = Other Pathologies
a,b

Different superscripts are significantly different within species (P<0.05) for

normal pathology verses cycling or noncycling females
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TABLE 5. Numbers of African elephants evaluated by transrectal
ultrasound, and categorized based on normal and abnormal urogenital
tract morphology within ovarian cyclicity status categories
African
Category
Normal

Cycling

Noncycling

Irregular

Not Monitored

31a

7b

6b

1

OC

1

UT c/t

1

2

VA c/t

2

1

OC, UT c/t

1

UT c/t, VA c/t

1

OP
OC, OP
OC, VA c/t

2

1

1

2

1

1
1

NM = Not monitored hormonally, OC = Ovarian Cysts, UT c/t = Uterine
Cysts/Tumors, VA c/t = Vaginal Cysts/Tumors, OP = Other Pathologies
a,b

Different superscripts are significantly different within species (P<0.05) for

normal pathology verses cycling or noncycling females
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TABLE 6. Comparison of results between the 2002, 2005, and 2008 reproductive assessment surveys for the SSP
population of Asian and African elephants. Data from 2002 and 2005 surveys were from Brown et al. [2004] and Proctor et
al. [2010], respectively.
Asian
2002
No. of Females
No. of Adult Females Monitored (%)
Not Cycling (%)3
Irregular Cycling (%)3
Not Cycling + Irregular Cycling (%)3
Females with U/S Data (%)2
No. of Reproductive Age Females (%)1
No. Monitored (%)1
No. Not Cycling (%)1
No. Irregular Cycling (%)1
Not Cycling + Irregular Cycling (%)1
No. of Females New to Survey (%)2
No. of New Females Monitored (%)
No. of New Females Cycling (%)3
No. of Returning Females Now Monitored (%)

African

2005

131

2008

116

2002

109

114

a

92 (79.3)

b

63 (57.8)

10 (13.3)

10 (10.9)

7 (11.1)

75 (57.3)
2 (2.6)

a

7 (7.6)

ab

9 (14.3)

2005

a

b

2008

128

136

a

93 (72.7)

17 (22.1)

29 (31.2)

29 (30.5)

b

15 (15.8)b

77 (67.5)
4 (5.2)

a

11 (11.8)

b

95 (69.8)ab

12 (16.0)

17 (18.5)

16 (25.4)

21 (27.3)a

40 (43.0)b

44 (46.4)b

70 (53.4)

69 (59.5)

57 (52.3)

50 (43.9)

66 (51.6)

62 (45.6)

a

57 (49.1)

a

b

94 (82.5)

96 (75.0)

93 (68.4)

46 (67.6)

49 (86.0)

38 (88.4)

64 (68.1)

75 (78.1)

73 (78.5)

a

b

68 (51.9)

43 (39.4)

6 (13.0)

4 (8.2)

2 (5.3)

15 (23.4)

2 (4.3)

4 (8.2)

3 (7.9)

4 (6.3)

8 (17.3)

19 (29.7)

24 (32.0)
8 (10.7)

a

32 (42.7)

22 (30.1)ab
8 (11.0)

b

30 (41.1)ab

8 (16.4)

5 (13.2)

6 (5.2)

9 (8.3)

6 (4.7)

38 (27.9)

5 (83.3)

2 (22.2)

2 (33.3)

17 (44.7)

0 (0.0)
21 (22.8)

1

12 (17.6)

Reproductive age = 11-35 years of age as established by the SSP.
Percentage of population total.
3
Includes all age groups except for immature/prepubertal females
a,b
Superscripts denote significantly different from 2002, 2005 and 2008 survey data
(P<0.05).
2
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14 (15.1)
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Abstract
This paper described anti-Müllerian hormone (AMH) secretion in Asian and African elephants of
different age groups and reproductive status. Overall mean concentrations did not differ (P>0.05)
between species, but were markedly higher in male than female Asian (31.01 ± 4.22 ng/mL, 0.19 ±
0.02 ng/mL) and African (40.27 ± 3.18 ng/mL, 0.17 ± 0.04 ng/mL) elephants, respectively. AntiMüllerian hormone secretion was not related to ovarian cyclicity status (cycling vs. noncycling)
(P>0.05), but was higher in prepubertal (0.40 ± 0.10 ng/mL) compared to reproductive age (8-35
years old; 0.18 ± 0.04 ng/mL) and aged (≥36 years old; 0.16 ± 0.03 ng/mL) females (P<0.05). In
males, AMH secretion was not affected by musth status, but was age-related (P<0.05), with
concentrations being higher in prepubertal (49.08 ± 6.11 ng/mL) as compared to aged (≥36 years old)
(22.27 ± 5.82 ng/mL) bulls; concentrations in mature bulls (8-35 years of age) (37.01 ± 3.17 ng/mL)
were similar to prepubertal and older bulls (P>0.05). We concluded that circulating AMH
concentrations in elephants were similar between species and not affected by reproductive status;
however, concentrations were significantly higher in males than females, and were elevated in
younger animals. The diagnostic value of AMH to assess fertility status of individual elephants
remains to be determined.

Keywords: anti-Müllerian hormone, ovary, granulosa cell, follicle, spermatogenesis
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1. Introduction

Elephant populations in western zoos are not self-sustaining and reproductive rates are low. One
problem is that some females do not exhibit normal ovarian cycles. In successive surveys, a marked
increase in overall rates of acyclic and irregular cycling activity has been observed, from 27% to 43%
in African and 16% to 24% in Asian cows between 2002 and 2008, respectively [1,2]. To create selfsustaining populations in the U.S., it has been estimated that a total of six female calves per species
must be produced annually [3,4]. This will not be possible if the rates of abnormal ovarian activity
continue to increase, and makes it imperative to identify causes of ovarian cycle problems.
Anti-Müllerian hormone (AMH), also known as Müllerian inhibiting Substance, (MIS), is a
dimeric glycoprotein hormone in the transforming growth factor-β (TGF-β) family. In the female,
AMH is produced by granulosa cells in the postpuberal ovary, with expression being highest in the
preantral and small antral follicles [5]. Anti-Müllerian hormone participates in primary follicle
formation during folliculogenesis by inhibiting excessive follicular recruitment by follicle stimulating
hormone (FSH) [6,7]. Recently, AMH has been used as a marker of fertility in women [8], cows [9]
and mice [10], with circulating concentration being correlated with the number of morphologically
healthy oocytes within the follicular reserve [11,12]. Clinically, tests for AMH commonly are used
to determine the onset of menopause in women, a state of reproductive cycle cessation due to ovarian
follicle depletion [13-15].
The cause of ovarian acyclicity in captive elephants is not known. However, in the wild, females
experience few ovarian cycles in their lifetime; most are either lactating (lactational anestrous) or
pregnant [16]. By contrast, the majority of captive females exhibit up to four cycles per year, and do
so continuously [17]. Ovarian function is dependent on the presence of primordial follicles that
develop into antral follicles during the estrous cycle [18]. In the elephant, the follicular phase is
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characterized by two follicular waves that occur approximately 20 days apart. Many follicles are
recruited into development, but only one ovulates [19,20]. In women, the number of ovarian follicles
eventually is exhausted and at that point reproduction ceases, the female enters menopause and stops
cycling [21]. It is not possible to quantify the number of small follicles in elephants by ultrasound
procedures; thus, an alternative method is needed to determine if acyclicity is related to follicle
depletion. Changes in AMH over time could specify whether captive elephants experience depletion
in ovarian follicle numbers as they age. This information is important so that management options
can be optimized for individual elephants. If the ovaries no longer contain a pool of healthy oocytes,
then hormonal or other therapies for treating acyclicity would be ineffective. But elephants with
functional follicles would be good candidates for treatment. What we lack is a valid test for
determining ovarian functional status in elephants.
Reproductive failure in captive elephants is not just a problem among females. Male elephant
infertility has been related to low libido and decreased semen quality [22,23]. Measurement of
testosterone generally is not a reliable marker of fertility in Asian or African species [24,25]. Semen
quality varies considerably in ejaculates between and within bulls, and it is not clear if these
differences are due to the collection method or some physiological problem [26]. In other species,
AMH is secreted by Sertoli cells during embryonic development, and along with testosterone from
the Leydig cells, it is responsible for regression of the Müllerian ducts and formation of the male
reproductive tract [6]. In men, Sertoli cells continue to produce AMH after reproductive tract
differentiation, but concentrations decrease gradually after puberty to nadir levels [27].
Measurements of AMH in serum and seminal plasma have been used as a marker for spermatogenic
function in men [28,29]. Thus, screening for AMH could be a first step in identifying reproductively
sound elephants for reproductive breeding programs. If AMH secretion is found to be correlated with
reproductive status or age, then it might be useful as a marker of fertility in male and/or female
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elephants. The objectives of this study were to: 1) validate an AMH ELISA for Asian and African
elephants; 2) establish baseline concentrations for males and females of both species; and 3)
investigate whether concentrations change with respect to age or gonadal functional status.

2. Materials and methods

2.1. Animals

Serum samples from Asian (n = 21 male, 20 female) and African (n = 20 male, 41 female)
elephants were used to assess AMH, progesterone (females) and testosterone (males) concentrations.
Blood samples were collected from either the saphenous vein in a rear leg or an ear vein by the zoo
veterinarian or elephant staff as part of the standard husbandry routine. Weekly samples over a 1year period were used for progestagen and testosterone analyses to assess reproductive status.
Females who exhibited progestagen concentrations of 0.05 ng/mL for at least a 1-year period were
deemed acyclic, while those whose progestagens showed normal cyclic patterns were categorized as
cycling [24]. Based on criteria established by Brown et al. [25], males exhibiting testosterone
concentrations > 30 ng/mL were considered in musth, whereas those with < 30 ng/mL testosterone
were categorized as non-musth. This project was approved by the National Zoo’s Animal Care and
Use Committee (NZP-IACUC # 09-04) and by individual zoological facilities where elephants were
housed. Yearly serum samples from each elephant were used for AMH analysis. In addition, yearly
samples were evaluated in one female over a 20-year period, between the ages of 42 and 62, and
monthly samples were analyzed in one 17-year old bull over a 1-year span to investigate changes in
AMH concentration over time within an individual.
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2.2. Serum hormone analyses

For females, concentrations of serum progestagens were quantified using a validated solid-phase
I125 progesterone radioimmunoassay (RIA) (Seimens Medical Diagnostic Solutions, Costa Mesa, CA)
[30]. For males, concentrations of testosterone were quantified using a validated solid-phase I125
testosterone RIA (Seimens Medical Diagnostic Solutions, Costa Mesa, CA) [31,1]. Assay
sensitivities were 0.03 ng/mL and 0.05 ng/mL for the progesterone and testosterone RIAs,
respectively. For both assays, intra-assay and inter-assay CV were <10% and <15%, respectively.
A human MIS/AMH enzyme immunoassay (EIA) (DSL-10-14400, Beckman Coulter, Inc., Brea,
CA) was used to measure AMH concentrations. The two-site EIA is specific for AMH and does not
crossreact with other members of the TGF-β family, including TGF-β, activin, or inhibin A and B
[10]. Assay sensitivity was 0.006 ng/mL, and the intra-assay and inter-assay CVs were 3.4% and
6.5%, respectively. The assay was validated for elephant serum by demonstrating parallelism
between serial dilutions of elephant serum (neat, 1:2 – 1:64) and the AMH standard curve.
Additionally, serum from castrates were utilized as a control and found to contain little to no AMH
concentrations compared to intact animals.

2.3. Statistical analysis

Statistical analyses were performed using SAS (SAS Institute, Inc. Cary, NC). First, PROC
MIXED of ANOVA was used to determine the effect of species, age, gender, and reproductive status
within gender on AMH concentrations. After the significant effect of gender was determined, a
second PROC MIXED of ANOVA was used for males and females separately to test the affects of
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species, age, and reproductive status on AMH concentrations. In cases where the null hypothesis was
rejected, Tukey-Kramer post hoc test was used to determine significant differences between groups.
Specifically, AMH concentration was compared between males and females, and then within gender,
comparison was done between species. Next, AMH was compared between two categories of
reproductive status (cycling vs. acyclic in females; musth vs. non-musth in males). Lastly, for both
males and females, AMH concentration was compared in three age categories: prepubertal (≤ 7 years
of age), reproductive age (8-35 years of age) and aged (≥ 36 years of age) for females; prepubertal (≤
7 years of age), mature (8-35 years of age), aged (≥36 years old) for male elephants. Age categories
for male and female captive elephants were based on hormonal and ultrasound data, and breeding
management recommendations [24,31,20,32]. Data are presented as means ± SEM. Differences
were considered significant if P<0.05.

3. Results

Table 1 summarizes overall mean serum AMH concentrations in postpubertal male and female
elephants. Concentrations varied more between than within individuals (P<0.05). Within gender,
there were no differences in AMH concentrations between Asian and African elephants, (P>0.05).
However, concentrations in bull elephants were more than 100 times higher than those observed in
females (P<0.05), with the exception of the four castrated males where AMH concentrations were
essentially undetectable. Because no species differences were found, AMH data were combined for
subsequent reproductive status and age analyses (Tables 2 and 3, respectively). Among pubertal
females, AMH concentrations did not differ with ovarian cyclicity status (i.e., cycling or noncycling;
P>0.05) (Table 2). Similarly, AMH secretion was not affected by musth status in bulls (P>0.05).
Among age categories, AMH concentrations in prepubertal females (≤ 7 years old) were more than
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double those of reproductive (8-35 years old) (P=0.013) and older (≥36 years old) aged females
(P<0.05) (Table 3). All females in the prepubertal category were not cycling. Concentrations of
AMH within a 20-year span in one Asian female (from 42-62 years of age) were relatively constant
between 42 and 58 years of age (mean, 0.26 ± 0.01 ng/mL) and then decreased from 0.22 ng/mL to
0.07 ng/mL between the ages of 58 and 62 (Figure 1). This female also stopped cycling at
approximately 61 years of age. Among bull age categories, AMH concentration were higher
(P<0.05) in prepubertal (≤ 7 years old) than aged (≥36 years) males, but were not different from those
of mature males (11-35 years) (P>0.05). Concentrations of AMH did not differ between the mature
and aged males (P>0.05) (Table 3). Testosterone secretion was higher in musth (38.71 ± 5.00
ng/mL) than in non-musth (31.12 ± 3.45 ng/mL) males, but there was no correlation between serum
AMH and testosterone concentrations (r =0.23; P>0.05). Anti-Müllerian hormone concentrations
were consistent within one 17-year old male elephant over a 1-year period (22.07 ± 0.62 ng/mL),
during which time he experienced a 4-week musth period (Data not shown).

4. Discussion

Previous studies in cattle [9], humans [8] and mice [10] show that AMH secretory patterns do not
necessitate intensive longitudinal sampling. Within age categories, concentrations are relatively
constant within an individual and are not affected by stage of the estrous cycle [9]. Thus, for this
study yearly samples were analyzed and divided into discrete age categories for analysis, as well as
into groups according to reproductive status. We inferred that concentrations of circulating AMH
were similar between Asian and African elephants; however, for both species, concentrations were
markedly higher in males than females, and there was a significant decline in concentrations as a
function of age.
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Anti-Müllerian hormone concentrations in human, mouse, and bovine females are shown to be
directly correlated with antral follicle number. As the follicular pool is depleted, AMH
concentrations decrease accordingly [34,10,9]. As a result, AMH is used as a marker of fertility and
an early detection test for menopause [8]. In women, circulating AMH concentrations analyzed using
the same assay are undetectable prepubertally, but increase to 3.8 ± 1.2 ng/mL after puberty [35].
Similarly, in the female mouse, AMH concentration peak at puberty (~29 ng/mL); followed by a
decline to 5 ng/mL by 16 months of age as follicles are depleted [10]. In cattle, AMH concentrations
of ~ 100 ng/mL are reported in prepubertal cows, which then decrease with age [36,9]. Although
much lower concentrations of AMH were detected in female elephants, the temporal profiles
appeared to be similar; with concentration being highest in younger animals (~0.60 ng/mL) compared
to those in the older age categories (~0.17 ng/mL).
One reason for conducting this study was to determine if follicle depletion normally occurs in
elephants, and if it is related to the lack of normal ovarian cyclicity observed in many captive
elephants [17,2]. Elephants in the wild can give birth into their 50’s, and many reproduce up to their
death [37,16,38]. However, they experience comparatively fewer cycles compared to captive
females. An elephant female probably loses 20 or more eggs each cycle as multiple follicles grow
before one is selected to ovulate [20]. Elephants do not reproduce well in zoos, in part because many
females do not cycle normally [1]. A potentially significant finding is that abnormal cycles occur
more in females ≥26 years of age [2]. Though by no means geriatric, data have suggested that
acyclic females may be experiencing premature reproductive aging and loss of functional follicles,
similar to menopause in humans [21]. In this study, AMH concentrations were not correlated with
ovarian cyclicity status. Therefore, our interpretation was that acyclicity in elephants is not caused by
a premature decline in the number of viable ovarian follicles. Longitudinal data from one older Asian
female (from 42 – 62 years of age) showed there may be a natural decline in AMH concentration
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over time in long-lived individuals and as reproductive cyclicity ceases. Unfortunately, very little
data exists on females in captivity older than 40 years of age, so data on only one female may not be
representative of all older elephants.
In the male, Sertoli cell derived AMH plays a key role in sex differentiation in utero causing the
regression of the müllerian ducts in the male fetus [39]. Postnatally, AMH concentrations measured
in the blood vary by age and species. This proved to be true for elephants, where mean AMH
concentrations in prepubertal males (~50 ng/mL) were highest before puberty and declined
significantly with age to about 20 ng/mL for bulls ≥ 36 years of age. Postnatal AMH concentrations
in men peak at 80-100 ng/mL, but then decline after puberty to concentrations less than 5 ng/mL
[40,41]. In cattle, AMH concentrations fall significantly from over 700 ng/mL prepubertally to less
than 200 ng/mL after puberty [36]. In the male mouse, AMH concentrations average ~160 ng/mL
prepubertally, then decrease in a pattern similar to that observed in the human to <2 ng/mL
postpubertally [41].
In the elephant, there was a significant gender difference in AMH secretion, with concentrations
being more than 100-fold higher in males than females. Interestingly, a similar gender difference in
AMH concentrations has been reported for cattle [36] and West Indian manatees [43]. In the
prepubertal male bovine, mean AMH concentrations at birth are more than 700 ng/mL in contrast to
120 ng/mL in the female [36]. In the male West Indian Manatee, the gender difference was even
more dramatic; mean AMH concentration in males was ~500 ng/mL ng/ml compared to only 0.08
ng/mL in the females [43]. Such vast comparative differences in AMH secretion suggest Sertoli cell
functional capacity may differ across species, as they are considered the major source of AMH in
males [6]. The absence of AMH immunoactivity in castrated bulls further confirms the testicular
source of this hormone in elephants.
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In human and mouse [44,41] and bovine [36] males, serum AMH and testosterone concentrations
are shown to be inversely correlated during development. The post-pubertal elephant experiences an
annual state of heightened sexual behavior and aggression called musth [45], which is associated with
marked elevations in testosterone production. However, in this study, there were no differences in
AMH concentrations between non-musth and musth males despite the dramatic testosterone
difference, and no correlation among all individuals between AMH and testosterone concentrations.
Therefore, AMH does not appear to be a good indicator of testicular steroidogenic activity in the bull
elephant. Whether AMH assessments could be used to assess general fertility in bull elephants,
however, remains to be determined.
Preliminary results from this study looked promising for AMH to be a potentially valid test for
assessing at least pubertal changes in gonadal function, and possibly other reproductive factors.
Reproductive tract pathologies such as ovarian cysts and tumors are common in a variety of species
[46,47], and do occur in elephants [23]. Serum AMH concentrations are shown to be markedly
elevated in insulin resistant patients with polycystic ovarian syndrome, and decrease after treatment
with Metaformin (Bristol-Myers Squib, New York), an anti-diabetic drug that helps suppress hepatic
glucose production and increases insulin sensitivity [48]. Until transrectal reproductive tract
ultrasound examinations become routine, many pathologies undoubtedly go undetected in elephants.
Early variations in granulosa cell derived AMH could be a useful marker for disease detection and
progression in the ovaries, as well as determining treatment options. For the male, AMH may play a
biological role during spermatogenesis. It is well known that there are certain physiological
conditions that decrease both quality and quantity of sperm in a male, including those related to
sickness and disease [49]. Inflammatory immune responses could illicit an increase in temperature,
interstitial fluid, and pressure that indirectly or directly compromises spermatogenesis, resulting in
temporary infertility [50]. Thus, we might expect to see decreases in circulating AMH concentration
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during times when a male is sick, stressed or injured [29]. Moreover, in men, seminal plasma antiMüllerian hormone are shown to be lower in individuals suffering from infertility, when compared to
fertile counterparts [51]. Although no correlation between serum AMH and testosterone
concentration was found in the elephants of this study, in men AMH is shown to be positively
correlated with testicular volumes, sperm concentration [52] and semen volume [53]. More
longitudinal sampling within the same individuals and over longer periods of time might reveal
relationships not evident in this study.

5. Conclusions

In summary, serum AMH concentrations in male and female Asian and African elephants have
been compared across age categories and between elephants of different reproductive status. From
these data, we conclude there were no differences in mean AMH concentration between elephant
species. However, overall mean AMH concentrations were markedly higher in males than females.
Anti-Müllerian hormone concentrations were highest in prepubertal individuals of both genders, and
decreased with age. However, AMH concentrations were not correlated with reproductive cyclicity
status in female elephants, so the observation of high rates of ovarian inactivity in the captive
population are likely not related to a loss of ovarian follicles. Only a limited number of males were
evaluated in this study, and all were considered healthy. The lack of a difference in AMH secretion
between musth and non-musth bulls suggests that Sertoli cell function is not appreciably altered in
that regard. However, more work is needed to determine the diagnostic value of AMH measurements
in assessing overall fertility status of mature bull elephants, especially in relation to physical or
psychological changes in health status.
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Figure 1. Profile of serum AMH concentrations over a 20-year period in an older female Asian
elephant (age 42 – 62 years of age). Regression analysis showed a significant decrease in AMH
concentration overtime.
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Table 1. Overall mean (± SEM) serum AMH concentrations in postpubertal male and female
Asian and African elephants.
Species

Gender

Elephants

Serum
samples

Mean AMH
(ng/ml)

AMH range
(ng/ml)

Mean AMH
within gender
(ng/ml)

Asian
African

Female
Female

n=18
n=41

n=18
n=46

0.19 ± 0.02
0.17 ± 0.04

0.06-0.34
0.04-1.43

0.18 ± 0.03a

Asian
African

Male
Male

n=20
n=18

n=29
n=32

40.27 ± 3.18
31.01 ± 4.22

4.94-62.53
0.75-74.14

35.64 ± 3.70b

Castrate

n=2

n=4

0.002 ± 0.001

0.000-0.004

0.002 ± 0.001c

a,b,c

Mean values with different superscripts are significantly different (P<0.05).
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Table 2. Mean (± SEM) serum AMH concentrations cycling and acyclic female and musth and
nonmusth male Asian and African elephants.

Reproductive
status

Elephants

Serum
samples

Mean AMH
(ng/mL)

AMH range
(ng/mL)

Cycling

n=15

n=16

0.24 ± 0.08

0.06 - 1.43

Acyclic

n=30

n=33

0.16 ± 0.02

0.05 - 0.76

Non-musth

n=14

n=38

31.12 ± 3.45

0.75 - 62.53

Musth

n=14

n=15

38.71 ± 5.00

4.94 - 60.76
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Table 3. Mean (± SEM) serum AMH concentrations in female and male Asian and African elephants
across age categories.
Elephants

Serum
samples

Mean AMH
(ng/mL)

AMH range
(ng/mL)

Females
Prepubertal1
Reproductive age2
Aged3
Males

n=2
n=20
n=11

n=5
n=31
n=28

0.59 ± 0.30a
0.18 ± 0.04b
0.17 ± 0.03b

0.05 - 1.55
0.05 - 1.43
0.04 - 0.76

Prepubertal1

n=3

n=9

49.08 ± 6.11a

17.5 - 74.14

Mature2

n=12

n=38

37.01 ± 3.17a,b

0.75 - 62.53

Aged3

n=5

n=14

22.27 ± 5.82b

1.58 - 54.45

Age category

a,b

Different superscripts designate significant differences in AMH concentrations among the age
categories (P<0.05) within each gender.
1
≤ 7 years of age
2
8-35 years of age
3
≥ 36 years of age

78

Evidence that Hyperprolactinemia is Associated with Ovarian Acyclicity in Female Zoo African
Elephants

Dow TLA,B, Brown JLA

Reproduction, Fertility and Development 2012. In Press

A

Smithsonian Conservation Biology Institute, Smithsonian National Zoological Park, 1500 Remount

Road, Front Royal, Virginia, USA
B

West Virginia University, Division of Animal and Nutritional Sciences, P.O. Box 6108,

Morgantown, West Virginia, USA

79

ABSTRACT

Currently, reproductive age (11-35 years old) female African elephants (Loxodonta africana) in U.S.
zoos are experiencing high rates of ovarian cycle problems (>40%) and low reproductive success.
Previously, our laboratory found one-third of acyclic females exhibited hyperprolactinemia, a likely
cause of ovarian dysfunction. This follow-up study examined the current state of hyperprolactinemia
in African elephants and found the problem has increased significantly to 71%. Circulating serum
progestagens and prolactin were analyzed in 31 normal cycling, 13 irregular cycling, and 31 acyclic
elephants for a 12-month period. In acyclic females, overall mean prolactin concentration differed
from cycling females (P<0.05), with concentration being either higher (n=22; 54.90 ± 13.31 ng/mL)
or lower (n=9; 6.47 ± 1.73 ng/mL) than normal. No temporal patterns of prolactin secretion were
evident in elephants that lacked progestagen cycles. In cycling females, prolactin was secreted in a
cyclic manner, with higher concentrations observed during nonluteal (34.38 ± 1.77 and 32.75 ± 2.61
ng/mL) than luteal (10.51 ± 0.30 and 9.67 ± 0.42 ng/mL) phases for normal and irregular females,
respectively. Overall prolactin means did not differ (P>0.05) between normal (16.11 ± 2.89 ng/mL)
and irregular (15.03 ± 4.17 ng/mL) cycling females. Of most concern was that over two-thirds of
acyclic females now are hyperprolactinemic, a dramatic increase from the one-third observed 7 years
earlier. Furthermore, females of reproductive age constituted 45% of elephants with
hyperprolactinemia. Until the cause of this problem is identified and/or a treatment is developed,
reproductive rates will remain suboptimal and the population non-sustaining.

Keywords: ovarian cyclicity, progestagens, gonadal dysfunction
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Introduction
At present, 41.1% of post-pubertal African female elephants in North America experience
estrous cycle abnormalities, such as irregular or no ovarian activity (Dow et al., 2011). Individuals
that do not cycle exhibit baseline concentrations of progestagens and are considered infertile (Brown
and Lehnhardt, 1997; Brown, 2000). One significant endocrine finding associated with abnormal
ovarian activity is high circulating prolactin concentrations; i.e., hyperprolactinemia (Brown et al.,
2004a; Meyer et al., 2004). In 2004, we completed a comprehensive study to determine if specific
hormonal imbalances were causative factors to ovarian acyclicity (Brown et al., 2004a). Of the 10
hormones examined [luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin,
thyroid stimulating hormone (TSH), estradiol, free and total triiodide thyronine (T3), free and total
thyroxin (T4), and cortisol], only prolactin differed and was significantly elevated in one-third (11/33)
of acyclic females.
Prolactin is a single-chain peptide hormone involved in a variety of biological processes, most
notably mammary gland development and lactation (Li et al., 1987; Li et al., 1989; Rillema, 1994;
Rillema, 1998). Secreted by the anterior pituitary gland, prolactin is under constant inhibitory control
by dopamine released from tubero-infundiular dopamine (TIDA) neurons in the arcuate nucleus of
the hypothalamus Ben-Jonathan, 1994). This hormone participates in a variety of physiological
processes important to reproduction (Freeman et al., 2000). It is the main luteotropic hormone during
gestation, supporting luteal progesterone secretion by decreasing the progesterone metabolizing
enzyme 20α-hydroxysteroid dehydrogenase (Lamprecht et al., 1969; Bast and Melampy, 1972;
Morishige and Rothchild, 1974), and is anti-atretic at the preovulatory follicle level by decreasing
intracellular calcium concentration (Lebedeva et al., 1998). In African, but not Asian elephants,
prolactin increases in a cyclic pattern during the nonluteal phase of the estrous cycle (Brown et al.,
2004a; Yamamoto et al., 2010), and is presumed to be important for facilitating follicle selection and
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development similar to that described in other species (Yoshimura et al., 1989; Larsen et al., 1990;
Yoshimura et al., 1991; Li et al., 2011).
Except for high levels of prolactin during pregnancy and lactation, hyperprolactinemia is a
pathologic condition at any age and a primary cause of amenorrhea and anovulation in several species
(Yu et al., 1981; Jones, 1989; Bachelot and Binart, 2007). In general, the negative effects of chronic
elevated prolactin secretion on reproductive function involve inhibition of hypothalamic GnRH
release and subsequent suppression of pituitary LH and FSH secretion, resulting in anovulation
(Bachelot and Binart, 2007). Temporary hyperprolactin secretion has been linked to sleep apnea,
anorexia, protein ingestion, hypoglycemia, stress, chest wall stimulation, and trauma (Jones, 1989;
Woolf et al., 1986; Billings et al., 2002). However, longer-term hyperprolactinemia-induced
infertility is generally associated with pituitary prolactinomas (Mah and Webster, 2002). Any
physiological or pharmacological process that disrupts dopamine secretion or interferes with the
delivery of dopamine to the portal vessels can cause hyperprolactinemia (Bachelot and Binart, 2007).
The etiology of hyperprolactinemia in elephants has yet to be established, but preliminary data
showing a dopamine agonist (cabergoline) and antagonist (domperidone) affects prolactin secretion
(Ball and Brown, 2006; Brown, unpubl. data) suggests it is under dopamine control similar to other
species.
The main objective of this study was to compare prolactin secretory patterns between cycling
and noncycling female African elephants, and determine if the percentage of acyclic females
experiencing hyperprolactinemia had changed since the last endocrine study published in 2004
(Brown et al., 2004a). We also assessed prolactin secretion in irregular cycling females, as it is now
clear that a number of elephants do not clearly fall into cycling or noncycling categories. The
eventual goal is to better understand the role of prolactin in normal and abnormal ovarian function,
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and to develop management or pharmaceutical strategies to mitigate cyclicity problems in captive
African elephants.

Materials and Methods
Animals and Sample Collections
Weekly serum samples from cyclic (n=31), irregular cycling (n=13), and acyclic (n=31)
postpubertal African female elephants were collected from an ear vein or saphenous vein in a rear leg
for 12 months for progestagen and prolactin analyses. Females that exhibited sustained progestagen
concentrations of <0.1 ng/mL for at least a 1-year period prior to this study were considered acyclic.
Normal cycling females were those that experienced consistent estrous cycles consisting of 4-6 week
nonluteal and an 8-10 luteal phases (Brown, 2000). As previously characterized by Brown and
colleagues (Brown et al., 2004b), irregular cycling females were those that exhibited extended
nonluteal phases (> 9 weeks) or shortened luteal phases (< 6 weeks), and/or the presence of marked,
inconsistent serum progestagen concentration during nonluteal or luteal phases as compared to those
of normal cycling females. As defined by Prado-Oviedo (2011), elephants with constant prolactin
concentrations ≥30 ng/ml were considered hyperprolactinemic. This project was approved by the
National Zoo’s Animal Care and Use Committee and by individual zoological facilities where
elephants were housed.

Hormone Analysis
Serum prolactin was measured by heterologous 125I double-antibody radioimmunoassay (RIA)
as previously described (Brown and Lehnhardt, 1997; Brown et al., 2004a). All assays were
conducted using a PBS-BSA buffer system [0.01 M PO4, 0.5% BSA, 2mM
ethylenediaminetetraacetic acid (EDTA), 0.9% NaCl, and 0.01% thimerosal, pH 7.6), with the
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exception of second antibody where BSA was omitted. An anti-human prolactin antiserum (NIDDKanti-hPRL-3) and ovine I125 prolactin label and standards (NIDDK-oPRL-I-2) were employed. The
assay was incubated at room temperature over a 3-day period. Assay sensitivity (based on 90% of
maximum binding) was 1.0 ng/ml with intra- and inter-assay CV <10% and <15%, respectively.
In contrast to most mammals, the major circulating luteal steroid in the elephant is not
progesterone, but 5α-reduced pregnanes (Hodges, 1998). Serum was analyzed using a solid-phase
I125 progesterone RIA (Seimens Medical Diagnostic Solutions, Costa Mesa, CA) that has been
validated for quantifying progestagens in elephant serum (Brown et al., 1991). Sensitivity (based on
90% of maximum binding) was 0.03 ng/mL and intra- and inter-assay CV were <10% and <15%,
respectively.

Data Analysis
Statistical analyses were performed using SAS (SAS Institute, Inc. Cary, NC). PROC GLM
of ANOVA for fixed-effects was used to determine overall differences in mean prolactin
concentrations for a one-year period between normal cycling, irregular cycling, and acyclic elephants.
Estrous cycle length was based on serum progestagen concentration and calculated as the number of
days from the first increase in serum progestagens until the next rise (Brown et al., 1999). Prolactin
peak and baseline concentrations were determined for each individual by an iterative process in
which high values were excluded if they exceeded the mean plus 2 standard deviations (Brown et al.,
1999). The highest concentration within a group of elevated samples was considered a peak, and
baseline values were those remaining after all high values had been excluded. For normal and
irregular cycling females, overall mean prolactin concentration during the nonluteal and luteal phases
of the estrous cycle were averaged compared. PROC MIXED of ANOVA for repeated measures was
used to determine differences in mean prolactin concentration between individual estrous cycles
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within each individual for normal and irregular cycling elephants. In cases where the null hypothesis
(no statistical differences among cyclicity groups) was rejected, Tukey-Kramer post hoc test was
used to determine significant differences among groups. Correlation analysis was used to determine
the relationship between prolactin and progestagens within normally cycling and irregular cycling
females. Data are presented as means ± SEM. Differences were considered significant at P<0.05.

Results
Cycling elephants exhibited 4.2 ± 1.2 estrous cycles over the 1-year study period (11 ± 0.4
weeks; range, 9 – 13 weeks). Irregular cycling elephants exhibited 2.4 ± 0.9 estrous cycles over the
same time period (18 ± 1.2 weeks; range 1 – 26 weeks). There was no clear progestagen pattern for
irregular females; 30.7% (4 of 13) had prolonged nonluteal phases (22.1 ± 1.1 weeks; range, 18 – 26
weeks), 23.1% (3 of 13) had short nonluteal phases (1.9 ± 0.8 weeks; range, 1 – 3 weeks ), 23.1% (3
of 13) had long luteal phases (12.3 ± 1.1 weeks; range, 12 – 14 weeks), and 23.1% (3 of 13) had short
luteal phases (3.7 ± 0.9 weeks; range, 3 – 5 weeks). Serum prolactin data in normal cycling, irregular
cycling, and acyclic elephants are summarized in Table 1. In both cycling groups, prolactin
concentration was about three times higher during nonluteal phases as compared to the luteal phase
(P<0.05). Overall mean concentration throughout the estrous cycle also was not different between
normal and irregular cycling females (P<0.05). By contrast, acyclic females exhibited higher
prolactin concentrations on average over the 1-year period than cycling elephants (P<0.05), at levels
that were similar to nonluteal phase concentrations in cycling females (P>0.05). Prolactin data in
acyclic females were further separated into ‘high’ (n = 22 of 31; 71%) and ‘low’ (n = 9; 29%)
categories, with the concentration in the ‘high’ group being nearly 4-fold greater than those during
the estrous cycle in cycling females (P<0.05). By contrast, concentration in the ‘low’ category were
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less than half of the overall estrous cycle or 1-year means, similar to those observed during the luteal
phase of cycling individuals (P<0.05).
Figures 1-4 illustrate representative profiles of serum progestagens and prolactin in normal,
irregular and noncycling female elephants, respectively. For normal cycling females, serum prolactin
concentrations followed a recurring pattern, with concentrations being higher during the nonluteal
phase (Fig. 1). In general, prolactin started to increase as the progestagens were returning to baseline,
peaked during the mid-nonluteal phase point, and then steadily declined to baseline as progestagens
rose during the subsequent luteal phase. On average, prolactin concentration peaked at 29.27 ± 3.68
ng/ml and progestagens at around 0.60 ± 0.21 ng/ml during their respective phases in the cycle.
Prolactin secretion in the irregular cycling females generally followed a similar pattern with
concentration highest during periods of low progestagens (Fig. 2A). In Figure 2A, two successive
waves of elevated prolactin of approximately equal duration were observed during a long nonluteal
period that lasted 17 weeks. Between these two waves, prolactin was at baseline for ~4 weeks.
Prolactin concentration was again low for about 5 weeks before a subsequent, normal duration (9
week) luteal phase, but with relatively low overall progestagen concentration. In the next cycle,
prolactin was increased throughout the following, extremely short (~1 week) nonluteal phase. In
Figure 2B, two successive waves of elevated prolactin were observed during a long nonluteal period
that lasted at least 20 weeks; progestagens were at baseline concentration at the start of the
monitoring period, and although monitoring began during the first wave of elevated prolactin, it
appears overall mean concentration during this wave was higher than those subsequent. A total of
three complete waves of elevated prolactin were observed in this individual, all of equal duration and
overall mean concentration. During the long nonluteal phase at the beginning of sampling, a biphasic
pattern of secretion was observed. After that, a normal 14-week cycle was observed, consisting of a
9-week luteal and 5-week nonluteal phase, followed by a comparatively long cycle ~24 weeks in
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duration; 13-week luteal and 11-week nonluteal phases. Again, prolactin was higher during nonluteal
periods, but the increase started towards the end of the nonluteal phase in the middle cycle and right
as progestagens were returning to baseline at the end of the luteal phase in the last cycle. In Figure
2C, two luteal periods were observed during the monitoring period, with peak progestagen
concentration of 0.38 and 0.46 ng/ml. Two successive waves of elevated prolactin of equal duration
were observed during the long, 34-week nonluteal period between these two luteal phases. Overall
mean prolactin concentration was higher in the first (20.83 ± 4.9 ng/mL) compared to the second
wave (10.62 ± 6.6 ng/mL). Overall, for irregular cycling females, prolactin increased up to 2 weeks
before to about 2 weeks after the start of a nonluteal phase. In addition, during periods of extended
nonluteal phases where progestagens were maintained at baseline concentration, more than one
biphasic elevation in prolactin was observed in 6 of 13 females (11 cycles). Figure 3 represents a
typical pattern observed in hyperprolactinemic elephants, with prolactin concentration consistently
elevated and showing little variation, and progestagens remaining at baseline. In Figure 4, both
serum prolactin and progestagen concentrations were at low, baseline concentrations with no cyclic
patterns observed. Serum prolactin and progestagen concentration generally remained at or below
6.0 ng/ml and 0.10 ng/ml, respectively.

Discussion
Ovarian cycle problems in female African elephants have been well documented for over a
decade, yet the etiology remains unknown. This study examined one suspected cause of ovarian
acyclicity in elephants: hyperprolactinemia (Brown et al., 2004a) and found that significant
perturbations in circulating prolactin concentrations are observed only in acyclic females. Even more
importantly, the proportion of females with hyperprolactinemia appears to have significantly
increased over the past 7 years. The females in this study represented 60% (31 of 51), 100% (31 of
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31) and 100% (13 of 13) of the normal cycling, irregular cycling, and acyclic female African
elephants, respectively, recently identified in a recent Elephant Species Survival Plan (SSP)
reproductive assessment survey (Dow et al., 2011). Hyperprolactinemia was observed in 71% of
acyclic females in this study, but in only 37% (11 of 30) of noncycling elephants in 2004 (Brown et
al., 2004a). Perhaps related, rates of ovarian cycle problems also have increased over this time
period, from 22% in 2004 (Brown et al., 2004b) to 41% in 2011 (Dow et al., 2011). Of the 30
acyclic females from the 2004 study, 5 are deceased, 9 are no longer monitored, and 16 are still
acyclic. Of the 16 acyclic females, 4 previously hyperprolactinemic individuals are still
hyperprolactinemic and 14 females previously with normal prolactin concentration are now
hyperprolactinemic (Brown et al., 2004a; Dow et al., 2011, Dow, unpubl. data). In both endocrine
studies, 100% of the acyclic elephants identified in SSP surveys were represented (Brown et al.,
2004a, present study), so there was not a selective bias towards hyperprolactinemic elephants. Cause
and effect has not been established because these two studies focused on only two 1-year periods of
time; however, the concomitant increase in ovarian problems and rates of hyperprolactinemia is
strongly suggestive of a physiological link between the two.
In women, hyperprolactinemia is a known primary cause of infertility, and has a diverse
pathophysiology (Yu et al., 1981; Jones, 1989). Prolactinomas account for 25-30% of functioning
pituitary tumors and are a major contributor to hyperprolactinemia (Webster et al., 1997). In some
cases, tumor presence can physically block the secretion of gonadotropins, thereby compromising
estrous cyclicity (Webster et al., 1997). There are numerous other conditions not associated with
pituitary tumors that can result in hyper prolactin secretion, such as sleep disorders, tuberculosis,
trauma and renal failure (Mah and Webster, 2002), although none are suspected to be a problem in
our study animals based on veterinary records. A variety of pharmaceuticals also have been shown to
either remove dopamine inhibition or directly stimulate prolactin secretion to cause an increase in
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prolactin secretion (La Torre and Falorni, 2007). These agents include neuroleptics: phenothiazines,
haloperidol; antihypertensives: calcium-channel blockers, methyldopa; psychotropic agents: tricyclic
antidepressants; and anti-ulcer agents: H2 antagonists (La Torre and Falorni, 2007). But again, we
have no evidence that any of the elephants in this study were exposed to prolactin-inducing chemical
agents.
In addition to physiological and pharmacological effects, several endocrine factors have been
identified as stimulants of prolactin synthesis: vasoactive intestinal polypeptide (VIP) (Nicosia et al.,
1983), thyrotropin-releasing hormone (TRH) (Tashjian et al., 1971) and estradiol (Lieberman et al.,
1978). VIP in the brain is synthesized and secreted in two distinct areas, the hypothalamus and
within lactotrophs in the anterior pituitary. One action of VIP is to stimulate prolactin mRNA
synthesis by enhancing adenyl cyclase and subsequent cAMP directly at the lactotroph, and/or
indirectly through deactivation of the tubero-infundibular dopamine system (Ajika et al., 1972;
Meites et al., 1972; Ben-Jonathan et al., 2008). Hypothalamic and lactotroph derived VIP has been
shown to increase prolactin synthesis during the same time dopamine is exerting an inhibitory effect
(Ben-Jonathan et al., 2008). It is possible that a secondary effect of acyclicity in elephants is an
increase in dopaminergic tone, resulting in elevated prolactin synthesis and suppression of
hypothalamic GnRH. Neither dopamine nor VIP have been evaluated in African or Asian elephants,
but given the obvious problem of hyperprolactinemia-related problems in the African species, such
investigations appear to be warranted.
Estradiol is a known stimulator of prolactin secretion working both directly and indirectly at
the anterior pituitary to increase prolactin synthesis and secretion (Lieberman et al., 1978). Estrogens
act at the hypothalamus to decrease dopaminergic tone and on lactotroph cells to increase TRH
receptors and block the dopamine inhibiting decrease in cAMP at dopamine 2 receptors (BenJonathan, 1994). TRH can increase prolactin production via direct stimulation by calcium or the
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subsequent phosphorylation of proteins through a calmodulin-dependent protein kinase (Tashjian et
al., 1971). A TRH challenge in a female African elephant resulted in an increase in serum prolactin
concentrations (Bechert, 1998). However, in the 2004 study of Brown and colleagues (Brown et al.,
2004a), serum estradiol did not appear to be a contributing factor to hyperprolactinemia in noncycling
African elephants. Thus, because the stimulatory effect of TRH on lactotrophs is mediated through
estradiol, it is unlikely that TRH is a likely candidate for prolactin synthesis and secretion
(Yamamoto et al., 2010; Prado-Oviedo, 2011). Finally, in women, obesity has been linked with
amenorrhea and an increase in dopamine secretion (Doknic et al., 2002), and there is some evidence
this may be the case for elephants. Captive African elephants are reported to be 27% heavier than
their wild counterparts (Ange et al., 2001), and a study by Freeman et al. (Freeman et al., 2009)
found ovarian acyclicity was associated with a higher body mass index in zoo females. In addition,
European zoos housing African elephants are experiencing similar problems (Clubb et al., 2009). A
study presently underway to correlate body weight and condition scores, subcutaneous fat deposits
and serum nutritional biomarkers with ovarian-pituitary function may shed light on these putative
relationships.
In African elephants, prolactin appears to participate in normal follicular development
because concentrations increase during the nonluteal or follicular phase of the estrous cycle and reach
maximum levels immediately preceding ovulation (Bechert et al., 1999; Brown et al., 2004a). In
other species, prolactin regulates follicular development by altering gonadatropin actions at both the
hypothalamic-pituitary and ovarian level, resulting in decreases in preantral and antral follicle
numbers (Larsen et al., 1990), cAMP levels and steroidogenic function (Gitay-Goren, 1989), and
aromatase activity (Tsai-Morris, 1983). Elephants are unique in that during the nonluteal phase they
exhibit two quantitatively similar LH surges approximately 21 days apart, which correspond with two
discrete follicular waves (Hermes et al., 2000; Lueders et al., 2010); only the second LH surge
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induces ovulation (Brown et al., 1999; Hodges, 1998). Prolactin has been shown to decrease
plasminogen and metalloprotease concentrations within preovulatory follicles (Yoshimura et al.,
1989; Yoshimura et al., 1990; Yoshimura et al., 1992), both of which play pivotal roles in the
degradation of tissue at the apex of an ovulatory follicle, facilitating follicle rupture and subsequent
extrusion of the oocyte (Smith et al., 1999). By decreasing enzymes involved in ovulation, increases
in prolactin during the early nonluteal phase of the elephant cycle may function to prevent ovulation
at the first LH surge. Prolactin then decreases immediately before ovulation (Brown et al., 2004a),
possibly resulting in an increase in plasminogen and metaloprotease activity that allows ovulation to
occur. By contrast, the Asian elephant also exhibits two LH surges, but no cyclic pattern of prolactin
secretion (Brown and Lehnhardt, 1997). It may be significant then, that hyperprolactinemia is only
observed in African elephants; prolactin may not play a significant role in controlling ovarian
function in the Asian species (Brown et al., 2004a).
Increases in prolactin secretion during the nonluteal phase were observed in both normal and
irregular cycling females. However, temporal patterns were more distinct in normal cycling
elephants, with a stronger negative relationship existing between the two hormones (r = -0.8)
compared to irregular cycling females (r = -0.6). Similar to progestagens, prolactin secretion patterns
for the latter were in fact irregular. Unlike in normal cycling individuals where prolactin was
elevated during the nonluteal phase until just before the ovulatory LH surge, in irregular cycling
females increases in prolactin were observed anywhere from two weeks before to about two weeks
after the start of the nonluteal phase, in some cases carrying over into the next luteal phase. In some
irregular females experiencing prolonged nonluteal periods, more than one increase in prolactin was
observed. This finding suggests that prolactin follows a somewhat regular pattern of secretion during
periods of low progestagens, with each wave lasting approximately 8-10 weeks, similar to the single
wave observed in normal cycling females.
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While over two-thirds of acyclic elephant females exhibited hyperprolactinemia in this study,
we also observed acyclic female elephants with consistently low circulating serum prolactin
concentrations and no cyclic temporal profiles. It is possible that in these females, a lack of estradiol
from growing follicles is responsible for reduced prolactin secretion. With no follicular development,
estrogens would not reach a threshold concentration to increase prolactin. Thus, low prolactin
concentrations might be a consequence of acyclicity and not a contributing factor. However, if the
problem is an increase in dopaminergic tone, constantly low prolactin secretion would result in the
lack of a cyclical profile. As previously mentioned, in other species prolactin participates in a variety
of regulatory mechanisms during the estrous cycle, both stimulatory and inhibitory (Tsai-Morris et
al., 1983; Gitay-Goren et al., 1989; Yoshimura et al., 1989; Zadworney et al., 1989; Larsen et al.,
1990; Martel et al., 1990; Matsuyama et al., 1990; Yoshimura et al., 1990; Yoshimura et al., 1991;
Yoshimura et al., 1992; Smith et al., 1999). Assuming prolactin plays a stimulatory role in follicular
development and ovulation in African elephants, its suppression could result in the types of ovarian
dysfunction observed in females with low prolactin.
In summary, prolactin secretory patterns in acyclic verses normal and irregular cycling female
African elephants are significantly altered. Although the exact mechanism of prolactin action in
elephants is still unclear, it appears that perturbations in prolactin synthesis, either too much or too
little, may be directly or indirectly involved in gonadal dysfunction. Most importantly, the frequency
of hyperprolactinemia appears to have dramatically increased and is now observed in 71% of acyclic
females, up from the 37% in 2004 (Brown et al., 2004a). The next step is to determine if a loss in
cyclical prolactin secretion during the nonluteal phase precedes acyclicity acting as a causative factor
or if constant low prolactin synthesis is a consequence of the acyclic state. Because our captive
African elephant population is not self-sustaining, it is imperative to have all reproductive-aged
females cycling. One potential treatment option involves the use of cabergoline, a dopamine receptor
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agonist that has been shown to temporarily decrease circulating prolactin concentration in
hyperprolactinemic elephants (Ball and Brown, 2006). A trial is now underway to determine if longterm cabergoline treatment (at least 1 year) will permit resumption of ovarian activity, similar to that
observed in women (Dekkers et al., 2010). By identifying causative factors of acyclicity, we hope to
develop proper courses of treatment to mitigate ovarian cycle problems in reproductive-age female
elephants, and prevent the population crash predicted for this species in zoos (Faust et al., 2006).
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TABLE 1. Circulating serum prolactin concentrations (mean ± SEM) in normal cycling, irregular cycling, and acyclic
female African elephants during the estrous cycle, and for the 1-year study period.
Overall Mean Prolactin Concentrations (ng/ml)
Age Range
(years)

No. of
Elephants

Nonluteal
Phase

Luteal Phase

Estrous
Cycle

1-year period

Group

Mean Age
(years)

Normal Cycling

29.1

16-39

n=31

34.38 ± 1.77a

10.51 ± 0.30b

16.10 ± 0.40

16.11 ± 2.89a

Irregular Cycling

34.5

23-48

n=13

32.75 ± 2.61a

9.67 ± 0.42b

15.03 ± 0.57

15.03 ± 4.17a

Acyclic
High
Prolactin

35.4

26.53

n=31

N/A

N/A

N/A

33.03 ± 5.93b

N/A

N/A

N/A

64.90 ±
13.31*

36.4

28-53

n=22

N/A
N/A
N/A
6.47 ± 1.73*
Low Prolactin
32.9
26-45
n=9
a,b
Within column, means without a common superscript significantly differed (P<0.05) for normal cycling, irregular cycling,
and acyclic females over a 1-year period or between nonluteal and luteal phases for normal cycling and irregular cycling
females
*
Values with asterisk subscripts were not included in statistical analysis
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Figure 1. Representative profile of serum progestagen and prolactin concentrations for a normal cycling female elephant.
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Figure 2A. Representative profiles of serum progestagen and prolactin concentrations for three representative irregular
cycling female elephants.
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Figure 2B. Representative profiles of serum progestagen and prolactin concentrations for three representative irregular
cycling female elephants.
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Figure 2C. Representative profiles of serum progestagen and prolactin concentrations for three representative irregular
cycling female elephants.
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Figure 3. Representative profile of serum progestagen and prolactin concentrations for an acyclic female elephant with high
prolactin concentrations.
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Figure 4. Representative profile of serum progestagen and prolactin concentrations for an acyclic female elephant with low
prolactin concentrations.
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Abstract
Perturbations in serum prolactin concentration have been identified as a common symptom among
captive acyclic African elephants. In the human, hyperprolactinemia and prolactin deficiencies are
significant causes of amenorrhea. Pituitary prolactin is held under constant inhibition by a
hypothalamic derived neurotransmitter, dopamine; thus, regulation via exogenous treatment with
antagonists or agonists has been successful in reinitiating normal ovarian cycles. Oral
administrations of Cabergoline (dopamine agonist; n=4) and domperidone (dopamine antagonist;
n=4) were studied as possible treatments for hyperprolactinemia or prolactin deficiency, respectively.
Changes in serum prolactin and progestagen concentrations in response to treatment were evaluated
to determine if regulation of prolactin synthesis can reinitiate normal estrous cyclicity. Overall mean
prolactin concentration decreased (P = 0.01) in cabergoline treated females (32.22 ± 14.75 ng/mL)
when compared to controls (77.53 ± 0.96 ng/mL). Overall mean progestagen concentrations
increased (P < 0.05) in treated females (0.15 ± 0.01 ng/mL). In contrast, control hyperprolactinemic
females maintained mean baseline progestagen concentration (0.07 ± 0.01 ng/mL). Overall mean
prolactin concentration increased (P = 0.005) during times of domperidone treatment (21.77 ± 3.69
ng/mL) when compared to controls (5.77 ± 0.46 ng/mL). Overall mean serum progestagen
concentration was not significantly different in the treated group (0.11 ± 0.01 ng/mL) when compared
to controls (0.07 ± 0.01 ng/mL). In conclusion, prolactin synthesis can be regulated with either a
dopamine agonist or antagonist resulting in a decrease or increase in serum prolactin concentration,
respectively. Although serum progestagen concentration increased in response to Cabergoline
treatment, whether estrous cyclicity sufficient for successful breeding was reinitiated could not be
determined.

Keywords: ovarian cyclicity, prolactin, domperidone, acyclicity, progestagens

109

Introduction
Over the last 10 years, incidence of irregular or a lack of estrous cyclicity have increased in
reproductive age (11-35 years) female African elephants in North American zoos (Brown et al., 2004;
Proctor et al., 2010; Dow et al., 2011). At present, 46.4% of post-pubertal captive African elephants
in North American zoos experience estrous cycle abnormalities (Dow et al., 2011). In a 2004 study,
Brown and colleagues found significant differences in circulating prolactin concentrations between
cycling and noncycling females; 25% of all acyclic females African elephants were
hyperprolactinemic. More recently, our lab investigated differences in circulating concentrations of
serum prolactin were found among normal cycling, irregularly cycling, and acyclic individuals, with
all acyclic females experiencing perturbations in prolactin secretion (Dow and Brown, In Review).
Hormonal analysis revealed that 71% of all acyclic females were hyperprolactinemic; a dramatic
increase from 25% just 7 years earlier (Brown et al., 2004; Dow and Brown, 2012). Interestingly, the
same study showed the remaining 29% of acyclic individuals experience abnormal prolactin secretion
profiles wherein circulating prolactin concentration is low and secreted in a constant rather than
cyclical pattern (Dow and Brown, In Review). Under normal circumstances, prolactin is an
important hormone during pregnancy for mammary gland development and subsequent milk
production (Neill and Nagy, 1994). During the estrous cycle, it increases during the follicular phase
in many species, including African, but not Asian, elephants, and is believed to be involved in
follicular development (Brown and Lehnhardt, 1997; Brown et al., 2004). However, chronically
elevated or deficient prolactin concentrations cause luteal insufficiency and infertility (Mah and
Webster, 2002; Benson, 2008).
Hyperprolactinemia is a primary cause of amenorrhea and anovulation in the human (Yu et
al., 1981; Jones, 1989). The three main causative factors of hyperprolactinemia resulting in infertility
in the human have been identified as either physiological (pregnancy and lactation); pharmacological
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(anti-inflammatories, analgesics, and H2 inhibitors); and pathological (pituitary prolactinomas) (Mah
and Webster, 2002). High concentration of prolactin in pregnant or nursing individuals acts at the
hypothalamus to increase sensitivity to estrogen, which subsequently suppresses the gonadatropinreleasing hormone/lutenizing hormone (GnRH/LH) pulse generator causing lactational amenorrhea
(McNeilly, 2001). Furthermore, increases in serum prolactin increase dopamine release from
dopaminergic neurons (Moore and Demarest, 1982). Dopamine not only acts to inhibit anterior
pituitary prolactin synthesis and secretion but also decreases GnRH secretion resulting in gonadal
dysfunction (Rolland and Corbey, 1977). Regardless of the cause or mechanism, an increase in
prolactin secretion would cause an increase in dopamine resulting in suppression of GnRH.
Although the mechanisms of action are not entirely clear, prolactin deficiency has been
associated with menstrual disorders, delayed puberty, infertility, and subfertility in humans
(Martikainen et al., 1989; Falk, 1992; Mukherjee et al., 2003; Van Aken and Lamberts, 2005). The
clinical signs of prolactin deficiency are dependent on the extent of the deficiency and may be nonspecific; in humans, prolactin deficiency often occurs in conjunction with other pituitary hormone
deficiencies (Roberts and Ladenson, 2004; Van Aken and Lamberts, 2005). In a 1988 study, in vitro
fertilization patients receiving bromocriptine, a dopamine agonist, after ovarian hyperstimulation
experienced a decrease in serum and follicular fluid prolactin, increased serum estradiol, accelerated
ovarian follicle growth, decreased in luteal phase progesterone concentration, and subsequent
shortened luteal phase length (Kauppila et al., 1988), suggesting induced hypoprolactinemia
interferes with ovarian function. Furthermore, prolactin has gonadotropic activity (Doppler, 1994;
Wise and Maurer, 1994; Lebedeva et al., 1998) and has been implicated in the regulation of ovarian
function in a number of species (Gaytan et al., 1997; Clarke and Cummings, 1989). Prolactin
increases during the follicular phase of the estrous cycle in response to positive feedback action of
follicular estrogens on the pituitary lactotroph cells (Lawson et al., 1993) and acts on specific ovarian
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receptors to regulate follicular activity (Besognet et al., 1996; Besognet et al., 1997). In addition,
healthy follicles contain higher follicular fluid prolactin concentrations than atretic ones (Lebedeva et
al. 1998). Follicular fluid prolactin is believed to be involved in angiogenesis and the stimulation of
ovarian epithelial cells, both actions are important for follicular development and formation of
corpora lutea (Castilla et al., 2010). By inhibiting the degeneration of surface epithelial cells and the
disruption of connective tissue in the follicle wall, prolactin, in conjunction with gonadotropins and
estradiol, aids in the process of oocyte maturation. Thus, high preovulatory concentrations of
prolactin could be important to the process of follicular growth, oocyte maturation and ovulation in
humans (Yoshimura et al., 1991).
The main objectives of this study were to determine the effectiveness of domperidone and
cabergoline to initiate cyclic prolactin secretion and treat hyperprolactinemia, respectively and,
thereby, restore cyclicity in captive African elephants. From a scientific standpoint, this study will
provide valuable new scholarly knowledge on the mechanistic control of prolactin secretion in
African elephants, as well as its role in ovarian follicular development and function. This information
is important for maximizing the breeding success of zoo elephants, and would reduce the need to
import animals from range countries to supplement captive populations. The cyclic regimen of oral
domperidone administration was hypothesized to result in an increase in circulating prolactin
concentrations, and an oral administration of cabergoline would decrease circulating prolactin
concentration, thereby facilitating follicular development and subsequent ovulation resulting in
progestagen synthesis.
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Materials and methods
Animals and sample collections
Sixteen postpubertal, acyclic female elephants ranging from 24 to 43 years of age and housed
in zoological facilities in North America were divided into two groups according to circulating serum
prolactin concentration. Acyclic hyperprolactinemic and prolactin-deficient females had a constant
mean serum prolactin concentration of ≥ 30 ng/mL (Prado-Oviedo, 2011) and ≤ 10 ng/mL (Dow and
Brown, 2012), respectively. Regardless of serum prolactin concentration, females that exhibited
sustained serum progestagen concentration ≤ 0.10 ng/mL for at least a one-year period prior to this
study were considered acyclic (Brown, 2000).

Experiment 1
Hyperprolactinemic, acyclic female elephants (n=8) were randomly assigned to one of two
treatment groups: oral administration of 2 mg Cabergoline (Dostinex©, Pfizer Inc., New York, New
York) encapsulated in clear vegetarian capsules derived from hydroxypropyl methylcellulose
(Capsuline, Inc., Pompano Beach, Florida) with dextrose (n=4) or placebo (dextrose capsule), each
given twice weekly for 12 months (n=4).

Experiment 2
Prolactin deficient, acyclic females (n=8) were randomly assigned to one of two treatment
groups: consisting of 2 g/day of domperidone (Equidone® oral gel; Equi-Tox Pharma, Inc., Central,
South Carolina) (n=4) or 2 g/day vehicle (n=4) each for four weeks, followed by eight weeks of no
treatment. Each 12 week regimen was repeated for 12 months. In accordance to the dosing schedule,
domperidone was administered on week 0-3; 12-15; 24-27; 36-39; and 48-51.
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Doses were determined via previously unpublished preliminary studies and with manufacture
input. Weekly blood samples were collected by venipuncture of an ear or saphenous vein by facility
staff for progestagen and prolactin analysis. This project was approved by the National Zoo’s
Animal Care and Use Committee and by individual zoological facilities where elephants were
housed.

Hormone Iodination
Highly purified prolactin (NIDDK-oPrRL-I-2) (A.F. Parlow, Torrance, California) was
iodinated using chloramine-T. For each iodination, 5 µg of hormone (in 20 µl of 0.5 M NaPO4, pH
7.6) was incubated with 1 mCi carrier-free Na-125I (10 µl) for 1 minute in the presence of 2.5 µg
chloramine-T (10 µl in 0.05 M NaPO4, pH 7.6). The reaction was stopped with sodium metabisulfite
(10 µg in 10 µl of 0.05 M NaPO4, pH 7.6) and labeled hormone separated from free 125I using anionexchange chromatography (AG 2-X8, 100-200 mesh, chloride form; BioRad Laboratories, Melville,
NY). Columns (1 x 5 cm) were prepared by equilibrating resin in 0.05 M NaPO4 (pH 7.6) followed
by successive elution with 2 ml each 0.5 M, 0.05 M with 5% bovine serum albumin (BSA) and 0.05
M NaPO4 (pH 7.6). The iodination reaction mixture was layered onto the column, and labeled
hormone was eluted with 2 ml of 0.05 M NaPO4 into a tube containing 1 ml phosphate-buffered
saline (PBS) with 0.1% BSA (pH 7.4) (Brown and Lehnhardt, 1997).

Hormone Analysis
Serum prolactin was measured by heterologous 125I double-antibody radioimmunoassay (RIA)
(Brown and Lehnhardt, 1997; Brown et al., 2004). All assays were conducted using a PBS-BSA
buffer system [0.01 M PO4, 0.5% BSA, 2mM ethylenediaminetetraacetic acid (EDTA), 0.9% NaCl,
and 0.01% thimerosal, pH 7.6), with the exception of secondary antibody where BSA was omitted.
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An anti-human prolactin antiserum (NIDDK-anti-hPRL-3) and ovine 125I prolactin label and
standards (NIDDK-oPRL-I-2) were employed. The assay was incubated at room temperature over a
3-day period. Assay sensitivity (based on 90% of maximum binding) was 1.0 ng/ml with intra- and
inter-assay CV <10% and <15%, respectively.
Unlike most mammals, the major circulating luteal steroid in the elephant is not progesterone, but
5α-reduced pregnanes (Hodges, 1998). Serum was analyzed using a solid-phase 125I progesterone
RIA (Seimens Medical Diagnostic Solutions, Costa Mesa, CA) that has been validated for
quantifying progestagens in elephant serum (Brown et al., 1991). Sensitivity (based on 90% of
maximum binding) was 0.03 ng/mL and intra- and inter-assay CV were <10% and <15%,
respectively.

Data Analysis
Statistical analyses were performed using SAS (SAS Institute, Inc. Cary, NC).

Continuous

data for prolactin and progestagen concentrations were analyzed using the repeated-measures analysis
of variance (ANOVA) of the PROC MIXED procedure of SAS, version 9.1.3 (SAS Institute, Inc.,
Cary, NC, 2004). Prolactin peak and baseline concentrations were determined for each individual by
an iterative process in which high values were excluded if they exceeded the mean plus 2 standard
deviations (Brown et al., 1999). The highest concentration within a group of elevated samples was
considered a peak, and baseline values were those remaining after all high values had been excluded.
Although the same statistical analyses were used for both experiments, data where not combined and
experiments were analyzed separately. Data are presented as mean ± SEM. Differences were
considered significant at P<0.05.
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Results

Experiment 1
Serum prolactin concentration was significantly different (P = 0.01) for the Cabergoline
treated group when compared to the controls (Figure 1). In addition to an effect due to treatment
there was also a significant effect of time (P = 0.001) and interaction of treatment by time (P =
0.0006) for treated compared to controls. Prolactin concentration began to decrease from an overall
mean concentration of > 80.00 ng/mL within the first week of Cabergoline administration in the
treated group and remained lowered at a mean of 32.22 ± 14.75 ng/mL for the remainder of the
treatment. For control females, mean overall serum prolactin concentration was maintained
constantly at 77.53 ± 0.96 ng/mL. Overall mean serum progestagen concentration was different for
the treated group (0.15 ± 0.01 ng/mL) when compared to controls (0.07 ± 0.01 ng/mL) (P < 0.05).
For reference, prolactin and progestagen profiles of a normal cycling elephant have been included
(Figure 5). Individual elephant profiles can be found in Appendix I.

Experiment 2
Serum prolactin concentration was significantly different (P = 0.005) for the domperidone
treated group when compared to the controls (Figure 3). On average, prolactin concentration
increased either during or within three weeks after domperidone administration and returned to
baseline during the eight weeks without domperidone. Overall mean serum prolactin concentration
for treated females was 21.77 ± 3.69 ng/mL compared to 5.77 ± 0.46 ng/mL in controls. Moreover,
overall mean peak prolactin concentration in response to domperidone treatment was 40.09 ng/mL
(range 14.00-80.00 ng/mL); no peaks were observed in control females. Overall mean serum
progestagen concentration was not significantly different in the treated group (0.11 ± 0.01 ng/mL)
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when compared to controls (0.07 ± 0.01 ng/mL). Individual elephant profiles can be found in
Appendix I.

Discussion
Infertility due to ovarian cyclicity abnormalities in post-pubertal captive female African
elephants in North America has increased by 19.1% in the last 10 years (Dow et al., 2011). Recently,
perturbations in normal prolactin secretion have been identified as a common factor in these same
acyclic individuals (Dow and Brown, In Press). The purpose of this study was to investigate whether
serum prolactin concentration could be regulated with oral administration of either a dopamine
agonist or antagonist. The hyperprolactinemic, acyclic females in this study treated with cabergoline
experienced an overall significant decrease in serum prolactin concentration and increase in serum
progestagen concentration in response to treatment. Prolactin deficient, acyclic individuals
responded to domperidone treatment with significant increases in overall serum prolactin
concentration but not serum progestagen concentration during times of drug administration. These
experiments are likely the first time a dopamine agonist (cabergoline) and antagonist (domperidone)
have been used in the African elephants to control prolactin secretion.
Cabergoline, a long-acting D2 receptor agonist, acts directly to stimulate dopamine receptors
on pituitary lactotroph cells causing an inhibition in prolactin synthesis and secretion (Di Salle et al.,
1982). Oral administration in hyperprolactinemic human patients has been shown to effectively
reduce serum prolactin concentrations by approximately 50% with few adverse side effects (Ferrari et
al., 1992; Pontiroli et al., 1987). Furthermore, in a western lowland gorilla (Gorilla gorilla gorilla),
Cabergoline was effective treatment for hyperprolactinemia and resulted in the resumption of ovarian
activity and a successful conception and birth (Chatfield et al., 2006). Cabergoline has been used to
significantly reduce the size of pituitary tumors and adenomas by reducing lactotroph cell size with a
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rapid involution of rough endoplasmic reticulum and Golgi apparatus (Nissim et al., 1982;
Rengachary et al., 1982; Tindall et al., 1982; Landolt et al., 1985), and subsequently decreased
prolactin secretion (Melis et al., 1989).
For the cabergoline treated females, three out of four elephants responded with a significant
decrease in overall serum prolactin concentration, which was maintained throughout treatment
period. The individual that did not respond to treatment had a mean overall prolactin concentration
of 73.92 ng/mL compared to the18.32 ± 6.91 ng/mL in other females. Possibly another exogenous or
endogenous factor was overriding the agonistic effect of cabergoline for this individual female. In
the human, a variety of pharmaceuticals have been shown to act to either remove dopamine inhibition
or directly stimulate prolactin secretion, both of which allow for a dramatic increase in prolactin
secretion (La Torre and Falorni, 2007). In addition, prolactinomas account for 25-30% of functioning
pituitary tumors and are a major contributor to hyperprolactinemia (Webster and Scanlon, 1997). Not
only could tumors in the pituitary cause an abnormal increase in prolactin secretion and subsequent
dopamine release, but tumor presence could physically block the secretion of gonadotropins, thereby
compromising estrous cyclicity (Mah and Webster, 2002). Likewise, tumor growth could result in
release of other pituitary derived hormones causing for perturbations in the hypothalamic-pituitaryovarian/adrenal axis resulting in infertility (Webster and Scanlon, 1997). Adenoma in a Western
lowland gorilla has been shown to cause hyperprolactinemia resulting in gonadal dysfunction
(Chatfield et al., 2006). Unfortunately, the contribution of pharmaceuticals and pituitary tumors on
hyperprolactinemia in the elephant is yet to be investigated.
Interestingly, although one female did not respond to cabergoline treatment with a decrease in
overall mean prolactin secretion, she did experience an increase in overall serum progestagen
concentration. Peak progestagen concentrations were 0.24, 0.28, and 0.19 with durations of 7 weeks,
7 weeks, and 12 weeks, respectively, for each luteal phase. Although mean overall prolactin
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concentration in this female remained at 73.92 ng/mL the range for concentration during treatment
was 13.02-80.00 ng/mL. Possibly prolactin concentration decreased just long enough to allow for
brief increases in progestagen concentrations. In normal cycling females, maximum luteal
concentration of immunoreactive progestins has been documented as 0.25-0.90 ng/mL (Plotka et al.,
1988; Kapustin et al., 1996). For this experiment, changes on the ovary via follicle development or
luteal structure presence were not monitored ultrasonographically. Six to eight luteal structures of
both nonovulatory and ovulatory nature are present on the ovary during each estrous cycle (Hanks
and Short, 1972; Smith and Buss, 1975; de Villiers et al., 1989; Hodges et al., 1997). In addition, the
ovarian cyclicity for the African elephant have previously been defined ultrasonographically (Hermes
et al., 2000; Hildebrandt et al., 2000). However, no correlations in reference to luteal structure size,
age, appearance, and progestagen content has been established (Hodges, 1998). Likely progestagen
synthesis was of adrenal rather than ovarian origin. In the human, pregnanediol was found in the
urine of ovariectomized, but not ovariectomized and adrenalectomized patients (Klopper et al., 1957).
Comparably, progesterone was isolated in adrenal venous blood 10-100 times greater than in arterial
blood sampled at the same time in sheep, cattle, and pigs (Balfour et al., 1957). Therefore, estrous
cyclicity may not have been actually reinitiated and progestagen biosynthesis was not occurring in
ovarian as opposed to adrenal tissue.
Domperidone is a specific dopamine 2 (D2) receptor antagonist that inhibits dopamine action
at the pituitary level and induces significant and prolonged (> 24 h) increases in prolactin secretion
(Redmond et al., 1992). Domperidone does not cross the blood brain barrier and, therefore, does not
elicit neuroleptic side effects like other D2 receptor antagonists (Strickland et al., 1994).
Domperidone has been shown to increase prolactin secretion in a variety of species, including the
horse (Brendemuehl and Cross, 2000); camel (Almaw et al., 2000); heifer (Jones et al., 2003); and
dog (Gómez-Ochoa et al., 2009). Increasing prolactin has been beneficial to equine reproduction,
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including improving follicular development, increasing ovulation and conception rates, and
preventing problems associated with dystocias and poor milk production (Cross, 1997). Furthermore,
mares treated with domperidone during seasonal anestrous developed follicles that were functionally
normal (Brendemuehl and Cross, 2000). For this experiment, all females treated with domperidone
experienced significant increases in overall serum prolactin concentration in response to treatment.
Oral administration of domperidone was given for four weeks followed by eight weeks of no
treatment for five treatment cycles; thus, one treatment cycle equaled 12 weeks. Out of 20 total
treatment cycles (five treatment cycles per elephant with four elephants being treated), prolactin
concentration increased during the four week period domperidone was being administered for 13
treatment cycles, within three weeks of treatment for four treatment cycles, at least three weeks
before treatment for two treatment cycles, and failed to respond for only one cycle.
In addition, like seen in the cabergoline treated females, maximum peak luteal progestagen
concentration was within a normal range during treatment. Importantly all treated and control
females were acyclic for at least one year prior to this experiment. In a seasonal breeding animal like
the horse, during the transition out of the anestrous period the mare does not ovulate during the first
estrous cycle and therefore serum progesterone concentrations remain lower than normal until after
the second estrous cycle (Oxender et al., 1977). In the sheep, progesterone is required to prime the
hypothalamus during the transition from anestrous into estrous for normal hypothalamic-pituitary
function to occur (Caraty and Skinner, 1999). Although the elephant is not a seasonal breeder,
periods of acyclicity may be similar to anestrous periods in those seasonal breeding species, and thus
similar mechanisms may be behind the transition into resumption of estrous cyclicity.
In summary, these experiments demonstrate that overall serum prolactin concentration can be
regulated by oral administration of cabergoline or domperidone in acyclic hyperprolactinemic or
prolactin-deficient female African elephants, respectively. However, it is unlikely that ovarian
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cyclicity was reinititated. Currently, the North American captive African elephant population is not
self-sustaining, thus it is crucial that all reproductive-aged females have normal estrous cyclicity.
Although we now have potential treatment protocols for these types of acyclic females, we have
nonetheless failed to define the mechanisms of action behind what causes these conditions.
Moreover, it is yet to be determined if acyclicity is caused by or causes perturbations in prolactin
synthesis. It is our ultimate goal with our current and future work to not only develop treatment
protocols to mitigate ovarian cycle problems, but also to identify factors contributing to acyclicity
and thus prevent the predicted population crash for this species in zoos (Olson and Wiese, 2000;
Faust et al., 2006).
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Figure 1. Serum prolactin concentrations in all Cabergoline treated (n=4) and control (n=4) hyperprolactinemic, acyclic
female African elephants.
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Figure 2. Serum progestagen concentrations in all Cabergoline treated (n=4) and control (n=4) hyperprolactinemic, acyclic
female African elephants.
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Figure 3. Serum prolactin concentrations in all domperidone treated (n=4) and control (n=4) prolactin deficient, acyclic female
African elephants. Black areas designate treatment times (Week 0-3; 12-15; 24-27; 36-39; and 48-51).
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Figure 4. Serum progestagen concentrations in all domperidone treated (n=4) and control (n=4) prolactin deficient, acyclic
female African elephants. Black areas designate treatment times (Week 0-3; 12-15; 24-27; 36-39; and 48-51).
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Figure. 5. Serum progestagen and prolactin concentrations in a single normal cycling female African elephant. Reprinted with
permission from Dow and Brown (2012).
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Summary and Conclusion
Acyclicity in captive female African elephants is an increasing idiopathic reproductive
problem. Acyclicity is not indicative of permanent infertility wherein normal cycling and acyclic
females have comparable serum anti-Müllerian hormone (AMH) concentration, which is used as
a marker of fertility in a number of species. To date, several factors have been identified as
possibly contributing to acyclicity; perturbations in serum prolactin concentration were
consistent in all acyclic individuals. Although treatment protocols manipulating serum prolactin
concentrations to within a normal range have been successful, no mechanism of action has yet
been identified. Moreover, it is unknown if abnormal serum prolactin concentration is a cause or
consequence of acyclicity in this species.
From the written survey the current reproductive status of all female elephants in North
American zoological facilities was assessed. This survey showed that ovarian acyclicity, along
with reproductive tract pathologies, is evident among all postpubertal age groups for both
African and Asian elephants. Although overall rates of ovarian acyclicity did not change
between 2005 and 2008, irregular cycles continued to increase, and in many females represent
the transition from a cyclic to an acyclic state. Geographical location of a facility was not found
to contribute to ovarian acyclicity, whereas management style, presence of a male within a
facility, breeding opportunities, age, and presence of tract pathologies all had significant
influences on estrous cyclicity status in female elephants. Moreover, there continues to be a
species difference in the types and degree of reproductive problems, with African elephants
apparently being more susceptible to factors affecting ovarian activity than Asian females.
Serum AMH concentrations in male and female Asian and African elephants were
compared across age categories and between elephants of different reproductive status. No
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differences in mean AMH concentration between elephant species were significant. However,
overall mean AMH concentrations were markedly higher in males than females. Anti-Müllerian
hormone concentrations were highest in prepubertal individuals of both genders and decreased
with age. However, AMH concentrations were not correlated with reproductive cyclicity status
in female elephants, so the observation of high rates of ovarian inactivity in the captive
population are likely not related to a loss of ovarian follicles.
Prolactin secretory patterns in acyclic verses normal and irregularly cycling female
African elephants were significantly altered. Although the exact mechanism of prolactin action
in elephants is still unclear, it appears that perturbations in prolactin synthesis, either too much
(hyperprolactinemic) or too little (prolactin deficient), may be directly or indirectly involved in
gonadal dysfunction. Most importantly, the frequency of hyperprolactinemia appears to have
dramatically increased and is now observed in 71% of acyclic females, up from the 37% in 2004.
Logically, the next step is to determine if a loss in cyclical prolactin secretion during the
nonluteal phase precedes acyclicity and whether it acts as a causative factor or if constant low
prolactin synthesis is simply a consequence of the acyclic state. Because the captive African
elephant population is not self-sustaining, it is imperative to have all reproductive-aged females
cycling.
The oral administration of cabergoline, a dopamine receptor agonist that has been shown
to temporarily decrease circulating prolactin concentration in hyperprolactinemic humans, or
domperidone, dopamine receptor antagonist used to increase serum prolactin concentration in
mares, have been proven to regulate prolactin concentrations in acyclic elephants. These
experiments demonstrated that serum prolactin concentrations can be regulated by oral
administration of cabergoline or domperidone in acyclic hyperprolactinemic or prolactin
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deficient female African elephants, respectively. Changes in prolactin concentrations are
directly reflective of treatment administration regimen; however, what causes the observed
change in concentration of progestagens is unknown. Currently, the North American captive
African elephant population is not self-sustaining, thus it is crucial that all reproductive-aged
females have normal estrous cyclicity. Although we now have potential treatment protocols for
these types of acyclic females, we have nonetheless failed to define the mechanisms of action
behind what causes these conditions. Moreover, it is yet to be determined if acyclicity is caused
by or causes perturbations in prolactin synthesis.
In conclusion, acyclicity in captive African female elephants in North American
zoological facilities is continuing to increase; all age categroeies of post-pubertal females are
affected. Among acyclic females a common factor has been identified wherein serum prolactin
concentration is either too high or deficient when compared to normal cycling elephants. Oral
administration of either a dopamine agonist or antagonist, depending on prolactin synthesis
abnormality, has shown to be effective in regulating serum prolactin concentration by restoring
the profile to normal parameters. However, whether treatment reinitiates estrous cyclicity is yet
to be determined.
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Appendix I.

Figure 1. Elephant 1. Serum progestagen and prolactin concentrations in a domperidone treated prolactin deficient acyclic female
African elephant.
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Figure 2. Elephant 2. Serum progestagen and prolactin concentrations in a domperidone treated prolactin deficient acyclic female
African elephant.
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Figure 3. Elephant 3. Serum progestagen and prolactin concentrations in a domperidone treated prolactin deficient acyclic female
African elephant.
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Figure 4. Elephant 4. Serum progestagen and prolactin concentrations in a domperidone treated prolactin deficient acyclic female
African elephant.
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Figure 5. Elephant 5. Serum progestagen and prolactin concentrations in a domperidone control prolactin deficient acyclic female
African elephant.
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Figure 6. Elephant 6. Serum progestagen and prolactin concentrations in a domperidone control prolactin deficient acyclic female
African elephant.
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Figure 7. Elephant 7. Serum progestagen and prolactin concentrations in a domperidone control prolactin deficient acyclic female
African elephant.
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Figure 8. Elephant 8. Serum progestagen and prolactin concentrations in a domperidone control prolactin deficient acyclic female
African elephant.
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Figure 9. Elephant 9. Serum progestagen and prolactin concentrations in a Cabergoline treated hyperprolactinemic acyclic female
African elephant.
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Figure 10. Elephant 10. Serum progestagen and prolactin concentrations in a Cabergoline treated hyperprolactinemic acyclic female
African elephant.
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Figure 11. Elephant 11. Serum progestagen and prolactin concentrations in a Cabergoline treated hyperprolactinemic acyclic female
African elephant.
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Figure 12. Elephant 12. Serum progestagen and prolactin concentrations in a Cabergoline treated hyperprolactinemic acyclic female
African elephant.
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Figure 13. Elephant 13. Serum progestagen and prolactin concentrations in a Cabergoline control hyperprolactinemic acyclic female
African elephant.
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Figure 14. Elephant 14. Serum progestagen and prolactin concentrations in a Cabergoline control hyperprolactinemic acyclic female
African elephant.
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Figure 15. Elephant 15. Serum progestagen and prolactin concentrations in a Cabergoline control hyperprolactinemic acyclic female
African elephant.
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Figure 16. Elephant 16. Serum progestagen and prolactin concentrations in a Cabergoline control hyperprolactinemic acyclic female
African elephant.
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